Virginia Commonwealth University

VCU Scholars Compass
Theses and Dissertations

Graduate School

2018

The interaction between ceramide-1-phosphate and Group IVA
cytosolic phospholipase A2 and its role in wound healing
Patrick MacKnight
Virginia Commonwealth University

Follow this and additional works at: https://scholarscompass.vcu.edu/etd
Part of the Biochemistry Commons, and the Molecular Biology Commons
© The Author

Downloaded from
https://scholarscompass.vcu.edu/etd/5633

This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It
has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars
Compass. For more information, please contact libcompass@vcu.edu.

©Henry

Patrick Reece MacKnight
All Rights Reserved

I

2018

The interaction between ceramide-1-phosphate and Group IVA cytosolic
phospholipase A2 and its role in wound healing

A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University

By

Henry Patrick Reece MacKnight,
BS in Biological Sciences
Texas A&M University of Commerce 2013

Director: Charles Chalfant
Department head
Department of Cell Biology, Microbiology and Molecular Biology
At the University of South Florida

Virginia Commonwealth University
Richmond, Virginia
June 2018

II

Acknowledgements

As I come to the end of my PhD training and look back on everything I have
experienced and learned, a phrase my mother always said comes to mind: “it takes a
village to raise a child”. While getting a PhD and raising a child are clearly different, one
thing is very similar, the amount of help and guidance it takes for both to be done properly.
With that said, I have several people I would like to thank specifically for helping me get
to this point in my life.
Firstly, Allen, Caleb, and Jordan, y’all have been pillars in my life and are the true
definition of loyalty and friendship. I could never have asked for three better people too
have shared the majority of my life. Thank you for your friendship and support during the
past 10 years of my education and I look forward too many more years of friendship in
the future.
To my graduate school friends thank all you, without y’all this day wouldn’t be
possible. Your help in classes was instrumental in my surviving the first years of grad
school, and your continued help with scientific conversation and ideas assisted in
progressing my knowledge base further than I ever would have done on my own.
To the Dupree Lab, words cannot describe the feelings I have towards y’all.
Savannah, thank you for your friendship, I am proud to say you are both my friend and
colleague, you helped make grad school bearable in the worst of times and helped extend
the good times. Dr. Dupree, thank you for all your guidance. This project would not have
progressed like it did without your help and for that I can never thank you enough.
To the Ryan lab, y’all are my adopted lab family and I can truly say I am blessed
to have had the opportunity to have y’all in my life. You took me in, gave me a place to
III

work, and were always willing to discuss science and help me with my project. Thank y’all
for everything and I wish the best for all of you in your future endeavors.
To the Chalfant lab, many members came through the lab during my tenure with
y’all. Some stood out more than others for better and worse, but I want to say thank you
specifically to a few individuals; Alexis, your guidance and friendship helped me get to
this point. I know I drove you crazy, but I would like to believe that it all finally got through
my thick head and I am now better for it. Margaret, you helped me any time I asked, even
if it was a lame project (NPC1). You were always willing to discuss science and give
guidance and for that I can’t thank you enough. Charles, I think you described my PhD
experience best in that “it was the best of times and it was the worst of times” but thank
you for your guidance and direction over the past 4 years.
To my committee, thank you for your guidance and advice throughout this whole
process, it has made the PhD experience significantly easier knowing I had such a
knowledgeable group of individuals available to help when needed.
To my family, I am going to keep this short because I just don’t have the space to
say everything I want to, and words just don’t describe all of my feelings, but thank y’all
for your never-ending support and encouragement. I hope that I have made y’all proud.
To Amelia, thank for everything. You are the love of my life and the reason I wake
up in the morning. Without you I never would have gotten to this point. You make
everything better and I could never have dreamed of having a wife half as incredible as
you. I look forward to our future together and can’t wait to see what adventures are
entailed. OK, honestly, I am crying, and my keyboard can’t take anymore tears, writing
acknowledgments is way more emotional than I expected...

IV

V

Table of Contents

Page
Copyright…………………………………………………………………………….…….……..I
Title Page………………………………….………………………………………....………….II
Acknowledgements………….…………...……………………………………...….…………III
Table of contents………………………………………………………...................……...…VI
List of Figures……..…………………..…………………………………………….…….......VII
List of Tables…………………………………………………………………….....….........…IX
List of Abbreviations……………..……...…………………………………………….....….…X
Abstract………………………………..….……………………………………………..…...…XI
Chapter 1

Introduction…..…..………………………………………………………………1

Chapter 2

The C1P/cPLA2α interaction in acute wound healing…………………...…10

Chapter 3

The C1P/cPLA2α in chronic wound healing…………………………………69

Chapter 4

Discussion………………………………………………………………………83

List of References……………………………...…………………………….........................86
Vita……………………………………………...............……………………………...……..103

VI

LIST OF FIGURES

Page
1.1

Phases of Wound Healing……………………………………………………………...8

1.2

Major biosynthetic pathways of eicosanoids……………….……………………….10

2.1

Strategy and design of the novel cPLA2α KI mice……………….....……………...39

2.2

Ablation of the C1P/cPLA2α interaction does not affect the in vivo wound
closure rate……………………………………………………………………………..41

2.3

Histological evaluation of healed wounds from WT, cPLA2α KI, and cPLA2α KO
mice demonstrated a distinct phenotypical difference……………………………..43

2.4

Healed wounds from WT, cPLA2α KI, and cPLA2α KO mice demonstrate
differences in collagen rod diameter and wound tensile strength……...…….…..45

2.5

The loss of the C1P/cPLA2α interaction causes an increase in migration velocity
and collagen deposition in primary dermal fibroblasts……………...……………..47

2.6

Genetic ablation of the C1P/cPLA2α interaction affects eicosanoid synthesis in
primary dermal fibroblasts and healed excisional wounds………...……...………49

2.7

Viral recapitulation “rescues” the cPLA2α KI phenotype in cPLA2α KO pDFs..…51

2.8

Exogenous addition of specific eicosanoids alters migration velocity in dermal
fibroblasts…………………………………………………..…………….………...…..53

2.9

Small molecule inhibitors of cPLA2α and FLAP alter the migration velocity of
cPLA2α KI dermal fibroblasts…………………………………………………...…….55

2.10

Primary dermal fibroblasts from cPLA2α KI mice demonstrate differential
localization of cPLA2α and FLAP……………………………………………............57

VII

2.11

A schematic depiction of the current mechanistic hypothesis of cPLA 2α regulation
in the presence and absence of ceramide-1-phosphate…………..….....………..59

3.1

Classification of the four stages of pressure ulcers…………………………...…...73

3.2

Genetic ablation of the C1P/cPLA2α interaction regulates wound closure in
pressure ulcers....................................................................................................75

3.3

cPLA2α KI Neutrophils infiltrate wounded tissue at a greater rate than WT
Neutrophils...........................................................................................................77

VIII

LIST OF TABLES

Page
2.1

In vitro lipid profile from mechanically injured primary dermal fibroblasts from WT,
cPLA2α KI, and cPLA2α mice…………………………………………………………61

2.2

In vivo lipid profile in acute excisional wounds from WT, cPLA2α KI, and cPLA2α
KO mice…………………………………………………………………………………63

2.3

The altered lipid profile in primary dermal fibroblasts from the cPLA 2α KI mouse
is cPLA2α-specific……………………………………………………………………...65

IX

LIST OF ABBREVIATIONS

C1P

ceramide-1-phosphate

LTB4

Leukotriene B4

cPLA2α

group IVA cytosolic

LTD4

Leukotriene D4

phospholipase A2

LTE4

Leukotriene E4

WT

Wild Type

5-HETE

5-Hydroxyeicosatetraenoic

cPLA2 KO

cPLA2α knockout

cPLA2 KI

cPLA2α knock in

IL-6

interleukin 6

IL-4

interleukin 4

LXA4

Lipoxins A4

IL-8

Interleukin 8

LXB4

Lipoxins B4

TNF-α

Tumor necrosis factor alpha

AA

arachidonic acid

NF- Κb

Nuclear Factor κ-light-chain

PLA2

phospholipase A2

acid
15-HETE

15-Hydroxyeicosatetraenoic
acid

Enhancer of Activated B cells CERK

ceramide kinase

ECM

Extracellular matrix

PTFE

Polytetrafluoroethylene

Hex- Cer

hexosylceramide

pDFs

primary dermal fibroblast

SPK1

Sphingosine kinase 1

FLAP

Five Lipoxygenase activating

TxA2

thromboxane A2

COX

cyclooxygenase

SMase D

Sphingomyelinase D

PGE2

prostaglandin E2

5-LO

Five Lipoxygenase

6-KetoPGF1α 6-Keto- prostaglandin F1α

LIGHT-/-

TNFSF14/LIGHT

LTA4

kDa

kilodalton

protein

Leukotriene A4

X

Abstract
The interaction between ceramide-1-phosphate and Group IVA cytosolic phospholipase
A2 and its role in wound healing
By
Henry Patrick Reece MacKnight B.S.
Dissertation Director: CHARLES E. CHALFANT
Department head, department of Cell Biology, Microbiology and Molecular Biology
at the University of South Florida

The bioactive sphingolipid, ceramide-1-phosphate (C1P), directly binds and activates
group IVA cytosolic phospholipase A2 (cPLA2α) to generate eicosanoids, which are key
mediators of biological processes such as wound healing. In this study, we explored the
role of the cPLA2α/C1P interaction in wound healing and repair using a novel genetic
knockin model where this lipid:protein interaction was ablated (cPLA2α KI). In this model,
a dramatic increase in dermal fibroblast infiltration into the wound environment was
observed in contrast to both WT and cPLA2α knockout (KO) mice. Using a biomechanical
approach, the enhanced infiltration of dermal fibroblasts into the wound correlated with a
notable increase in wound tensile strength (>5-fold) in the cPLA2α KI compared to WT
and KO mice. Furthermore, a significant increase in the orderly deposition of Type I
collagen was observed, demonstrating that loss of the cPLA2α/C1P interaction enhanced
wound maturation. These findings translated in vitro, as KI dermal fibroblasts showed a
significantly increased rate of collagen deposition, as well as an increase in migration
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velocity in comparison to both WT and KO fibroblasts. Additional mechanistic studies
revealed an altered eicosanoid profile of reduced pro-inflammatory prostaglandins (e.g.,
PGE2) and increased levels of specific HETE species (e.g., 5-HETE) in the KI fibroblasts
and wounds. Additional studies demonstrated a key role for 5-HETE in dermal fibroblast
migration and collagen deposition. These studies are the first to demonstrate a key in vivo
biological mechanism regulated by a structurally defined protein:lipid interaction.
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Chapter 1
Background

1.1 Wound Healing
Wound healing is the process in which the body repairs damage to skin or tissue.
For wound healing to occur properly, four distinct phases must happen in an orderly and
timely fashion: hemostasis, inflammation, proliferation, and remodeling. While these
phases are uniquely identifiable, there is significant overlap between them (Fig. 1.1).
The initial phase, hemostasis, begins immediately following injury and is generally
classified as the body’s attempt to regulate the wound site by preventing blood loss. This
occurs when platelets come in contact with collagen, which triggers a molecular cascade
causing platelets to aggregate, forming a plug at the wound site designed to halt bleeding
(Hawiger, 1987). This occurs in tandem with with production of signaling molecules such
as eicosanoids released by ruptured blood vessels, causing nearby vessels to spasm and
prevent further blood flow to the affected area. Though this period is short lived,
approximately 10 minutes, it is critical for halting blood flow and recruiting inflammatory
cells into the wound environment (RASCHE, 2001). As the clotting cascade is in motion,
various cells begin releasing cytokines, growth factors, and eicosanoids, which both
attract and direct cells during the wound process.(Gonzalez, Costa, Andrade, & Medrado,
2016) The release of these signals is classically considered the period in which the
inflammatory phase begins. The inflammatory phase can be divided into two steps, early
and late inflammation.
Neutrophils are the predominant cell type that exists in the early inflammatory
period. Their primary role is to prevent infection by killing invading bacteria entering the
1

body through the open wound. They achieve this goal by producing antimicrobial
peptides, reactive oxygen species, and proteases. (Wilgus, Roy, & McDaniel, 2013) In so
doing, there are often negative secondary effects, as the same tools used to fight bacteria
also have negative effects on the host. Therefore, careful regulation of neutrophil activity
in the wound environment is needed to insure productive continuation the of wound
healing process. As the neutrophil response wanes, the wound transitions to the late
inflammatory period in which we begin to see an increase in macrophage populations.
Macrophages play two major roles in the wound environment: first, they cleanse the
wound by phagocytizing bacteria, damaged tissue, and other immune cells, while also
releasing proteases that help to clear damaged tissue.(Wilgus et al., 2013) Secondly,
macrophages react to the often-hypoxic environment of the wound by producing factors
that stimulate angiogenesis and re-epithelialization, and activate epithelial cells and
fibroblasts to produce extracellular matrix proteins leading to granulation tissue.
Significant overlap is seen between the end of the inflammatory phase and the
beginning of the proliferative phase. The end of the inflammatory phases is signaled by a
decrease in inflammatory mediators, neutrophils, and macrophages. This signals for the
infiltration of the primary cell involved in the proliferative phase: fibroblasts. During the
proliferative phase, the wound undergoes angiogenesis, collagen deposition, and
epithelization. Angiogenesis, the process by which new vasculature is formed in the
wound environment (Eming, Krieg, & Davidson, 2007), occurs through a multifaceted
cascade, in which first macrophages release growth factors that stimulate and activate
endothelial cells. These activated endothelial cells begin to separate from other cells as
well as the surrounding tissue, by breaking down the junctions that keep them adhered
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to their local environment. In conjunction with endothelial cell activation, cellular proteases
in the environment also assist in freeing endothelial cells from the vascular basal lamina.
Once free, the endothelial cells respond to chemotactic signals originating from the wound
environment and migrate towards the wound. While migrating, these cells begin to lay
down new vessels, which play a key role in providing the wound environment with the
nutrients required for cells such as fibroblasts to proceed into the proliferation phase. As
angiogenesis is occurring, the wound environment becomes less hypoxic. Increased
oxygen tension is part of a trigger for fibroblast influx into the wound site. This is
paramount to wound healing, since one of the main roles of fibroblasts is depositing type
I collagen. Prior to this, the main structural components of the wound environment are
type III collagen and fibronectin, which lack adequate tensile strength to permanently
keep a wound closed when put under stressors from the outside.(Greenhalgh, 1998)
Once collagen has been deposited and the granulation tissue has been formed,
epithelization can occur. During epithelization, cells at the edges of the wound site begin
to migrate inward and continue migrating and proliferating until both sides meet. The final
portion of the proliferation phase involves contraction. This is considered one of the most
important events in wound healing, due to the fact contraction is responsible for wound
closure.(Chitturi et al., 2015; Tomasek, Gabbiani, Hinz, Chaponnier, & Brown, 2002)
Contraction is largely regulated by a specialized fibroblast called myofibroblasts, which
are denoted by expressing α-smooth muscle actin and resembling smooth muscle cells
in their capacity for generating strong contractile forces.(R. A. F. (Richard A. F. . Clark &
Henson, 1988) In normal healthy healed wounds, myofibroblasts subsequently undergo
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apoptosis, preventing over contraction associated with significant scar tissue formation
and weaker wound healing.(Li & Wang, 2011)
The final phase of wound healing is the remodeling phase. As implied by the name,
this phase involves the breakdown, generation, and reorganization of the wound
environment, with the goal of generating a stronger wound that will have approximately
80% of the tensile strength of the original uninjured tissue.(Morton & Phillips, 2016).
During this phase type III collagen is degraded and converted to type I, and the excess
vasculature previously needed for nourishing cells during the healing process begins to
fade through apoptosis. The remodeling phase never truly ends in wound healing; the
cells continue to rearrange and make the wound stronger. As previously stated, the
wound healing process is a complicated and delicate process that requires many moving
parts in order to be accomplished properly. In the next section we will go on to describe
in greater detail several of the signaling molecules involved in the healing process.

1.2 Signaling Molecules in wound healing
To this point it should be clear that wound healing is a complicated process
requiring considerable cellular cross talk between the cells involved. This cross talk is
accomplished by cells producing signaling molecules, such as cytokines, growth factors,
and lipids, which can either act on the cell which produced them in an autocrine manner
or be excreted and act on neighboring cells in a paracrine manner. In this section we will
examine the members signaling molecules and how they interact to regulate the wound
healing process.

4

Cytokines are small proteins (5-25 kDa) that make up a large class of cellular
signaling molecules produced by a myriad of cell types and have various functions in
cellular systems. Studies done by numerous investigators have continually demonstrated
the important role of cytokines in wound healing. To highlight this, we will discuss several
cytokines and the important work that has demonstrated their role in wound healing. We
begin with interleukin 6 (IL-6), a well described cytokine shown to play a significant role
in inflammation. The importance of IL-6-regulated inflammation in wound healing was
demonstrated when Gallucci and colleagues examined the wound healing process in IL6-deficient (KO) mice. Wounded IL-6 KO mice displayed a delayed wound healing
phenotype associated with delays in macrophage infiltration, fibrin clearance, and
vascularization (Lin, Kondo, Ishida, Takayasu, & Mukaida, 2003; McFarland-Mancini et
al., 2010) These data demonstrated that timely initiation of inflammation is essential for
proper wound closure.
Another important player in the wound healing process is interleukin 4 (IL-4). IL-4 is
a 20kDa cytokine mainly produced by T-lymphocytes and mast cells that has been shown
to have distinct biological effects on multiple cell types. Of interest is work done by Gillery
and colleagues implicating IL-4 as a molecule that regulates extracellular matrix
deposition from fibroblasts.(Gillery et al., 1992) This study demonstrated that exogenous
addition of recombinant IL-4 on fibroblast monolayers directly regulated collagen gene
expression, suggesting IL-4 is an essential for proper wound closure.
Interleukin 8 (IL-8) is another cytokine shown to play a large role in the wound
healing process by regulating keratinocyte proliferation as well as acting as a chemotactic
reagent for neutrophil influx.(Rennekampff et al., 2000)
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Tumor necrosis factor alpha (TNF-α) is a cytokine that for a significant time was
shown to act as both a positive and negative regulator in the wound healing process
(Rapala, 1996). As of recently, new research using TNF-α neutralizing antibodies
demonstrated a reduction of leukocyte recruitment and NFB activation, as well as an
increase macrophages. (Ashcroft et al., 2012) In contrast, extracellular matrix (ECM)
synthesis was upregulated during treatment with TNF-α neutralizing antibodies. This work
shows that though TNF-α plays an important role in inflammation, unregulated expression
could lead to a chronic non-healing wound.
In addition to cytokines, various lipid classes such as ceramides and eicosanoids
have been shown to play an integral role in wound healing. Early examining the role of
ceramides in wound healing demonstrated an important role, in which hexosylceramide
(Hex-Cer) was shown to improve neovascularization in a rabbit wound chamber
model.(Niinikoski, Laato, Tschannen, & Fraefel, 1986) Additional work also demonstrated
an important role for Sphingosine kinase 1 (SPK1), a key enzyme in sphingolipid
metabolism, in wound healing. By using an inducible diabetic rat model and
overexpressing SPK1 in the wound environment for 21 days, Yu and colleagues showed
that increased levels of SPK1 significantly increased wound closure rate as compared to
untreated control mice.(Yu, Yuan, Xu, Zhang, & Duan, 2014)
Eicosanoids make up one the most important classes of lipids in the wound healing
process and are comprised of subclasses, such as prostaglandins, prostacyclins,
thromboxanes, leukotrienes and lipoxins. Eicosanoid synthesis begins with the initial ratelimiting step of arachidonic acid (AA) formation, via the activity of phospholipase A2 (PLA2)
In many cases, inflammatory agonists such as cytokines induce the activation and
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translocation of cytosolic phospholipase A2 (cPLA2a) in either a Ca+2-dependent or –
independent manner, at which point AA is acted upon by various enzymes giving rise to
a myriad of eicosanoids. (Fig. 1.2) When assessing the role eicosanoids play in the
healing process, one of the initial mediators is thromboxane A2 (TxA2), which promotes
hemostasis through signaling for vasoconstriction, platelet aggregation, and monocyte
infiltration.(Lefer, 1985) Early in the healing process the cyclooxygenase (COX) enzymes
are induced, which regulate the production of specific prostaglandins and prostacyclins,
such as prostaglandin E2 (PGE2) and 6-Keto- prostaglandin F1α (6-KetoPGF1α), both of
which play roles in vasodilation and platelet disaggregation.(Sandulache, Parekh, LiKorotky, Dohar, & Hebda, 2006) As the hemostasis phase begins to end, the
inflammatory phase begins. During this phase we see significant increases in
proinflammatory eicosanoids such as Leukotriene A4 (LTA4), Leukotriene B4 (LTB4), and
5-Hydroxyeicosatetraenoic acid (5-HETE), which are associated with immune cell
infiltration.(Borgeat, Hamberg, & Samuelsson, 1976; Brady, Persson, Ballermann,
Brenner, & Serhan, 1990) Towards the end of the inflammatory phase, production of
Lipoxins A4 and B4 (LXA4) (LXB4)(Cianci et al., 2016) increases, signaling the exodus of
immune cells and the infiltration of cells responsible for ECM deposition and wound
closure.
What is abundantly clear at this point is wound healing is an intricate and delicate
dance in which a myriad of interactions occur between various signaling molecules,
resulting in complex regulation processes that attempt to insure rapid, orderly, and proper
wound closure. Further research into understanding these interactions is necessary to
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advance our ability to treat and improve the quality of life of injured individuals, which we
will discuss in future chapters of this dissertation.
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Figure 1.1 The 4 Phases of Wound Healing. Wound healing is divided into four distinct
but overlapping phases: Hemostasis, Inflammation, Proliferation, and Remolding. During
hemostasis blood clot formation and vasoconstriction occur in order to stop bleeding and
collect local immune cells. The inflammatory phase is indicated by an influx of immune
cells such as neutrophils and macrophages These cells play an essential role in cleaning
the wound and prepping it for closure. Once macrophages have begun to exit the wound
environment the proliferative phase can be begin, in which fibroblasts invade and begin
the process of laying down new connective tissue and micro blood vessels (granulation
tissue) as well as collagen deposition. Finally, in the remodeling phase the wound is
allowed to mature by degrading the type III collagen that was laid down in the early phases
of healing. Along with degradation, collagen fibers are rearranged and cross-linked. If
healing continues in a timely manner, eventually the healed wound will reach about 80%
of its original strength.
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Figure 1.2 Major biosynthetic pathways of eicosanoids. Schematic of major
eicosanoid pathways containing lipoxygenase, cyclooxygenase, and P450 enzymes.
Abbreviations: Resolvin D1-6 (RvD1-6), Resolvin E1-2 (RvE1-2), Protectin D1 (PD1),
Maresin 1-2 (MaR1-2), Leukotrienes A4,B4,A5,B5 (LTA4,LTA5,LTB4,LTB5), Prostaglandin
H3,I3,E3,G2,H2,E2,D2,F2,I2 (PGH3, PGI3, PGE3, PGG2, PGH2, PGE2, PGD2, PGF2
PGI2,), Thromboxanes A2,B2 (TxA2TxB2)

12

Chapter 2
The C1P/cPLA2α interaction in acute wounds
2.1 INTRODUCTION
Wound healing is a dynamic process involving four main phases during which a
myriad of cells and signaling molecules interact to complete the healing process in a
timely and orderly fashion. The four distinct, yet overlapping phases, that make up the
healing process are hemostasis, inflammation, proliferation, and remodeling.(R. A. F.
Clark, 1988; Enoch & Price, 2004) During hemostasis, clotting factors work in tandem,
constricting blood vessels to decrease bleeding.(Versteeg, Heemskerk, Levi, & Reitsma,
2013) As the hemostasis phase ends, the wound transitions into the inflammatory phase,
where several hallmark events occur: vasodilation, increased vascular permeability, and
lastly neutrophil and macrophage infiltration into the wound site.(Diegelmann, Evans, &
others, 2004; M.-H. Kim et al., 2008; Koh & DiPietro, 2011) After the wound has been
cleared of any foreign debris and is properly prepped by the cells involved in inflammation,
the proliferation phase begins, at which point fibroblasts and keratinocytes migrate into
the wound and initiate wound closure. Additionally, during this phase, angiogenesis
occurs.(Broughton, Janis, & Attinger, 2006; Sivamani, 2014a) The final phase of the
healing process is remodeling, which involves formation of new epithelial layers as well
as increased deposition and crosslinking of collagen. Once completed, the healed wound
has approximately 80% of the original tissue strength.(Ireton, Unger, & Rohrich, 2013)
This study focuses on the role of eicosanoids in wound healing. These bioactive
lipids have emerged as key players involved in the normal wound healing process. As
such, a manifestation of impaired wound healing is the development of an imbalance
13

between pro- and anti-inflammatory lipids such as the arachidonic acid (AA)-derived
eicosanoids lipid mediators.(Dhall et al., 2015b) Specifically, PGE2 has been implicated
in the regulation of cell migration and meandering during the healing process of acute
wounds.(White et al., 2005a) Leukotrienes are another class of eicosanoid that play a
major role in the wound healing process. For example, leukotriene B 4 (LTB4) recruits
neutrophils to areas containing damaged tissue (Luo et al., 2017), which as previously
stated, is one of the initial phases of the wound healing process.
In addition to the healing of acute wounds, bioactive lipids contribute to the
impaired healing of chronic wounds. For example, the excess inflammation associated
with impaired healing of pressure ulcers correlates with high levels of pro-inflammatory
eicosanoids (e.g., LTD4, LTE4, PGE2).(Dhall et al., 2015b) Blockade of COX-2-derived
eicosanoids (e.g., PGE2) reduces inflammation and improves the healing of pressure
ulcers in mice.(Romana-Souza, Santos, Bandeira, & Monte-Alto-Costa, 2016) Localized
excess of PGE2 has also been linked to delayed wound healing and inhibition of fibroblast
function.(White et al., 2005b) Furthermore, PGE1, an anti-inflammatory prostaglandin
acting in opposition to the pro-inflammatory PGE2, is approved to treat human
wounds.(Co., 2010) Additional reports indicate that the bioactive fraction in platelet-rich
plasma for wound therapy is a lipid component and that nutritional formulations containing
pro-resolution lipids decrease the progression of pressure ulcers.(Lauren Alexis Hoeferlin
et al., 2015; Theilla et al., 2012) Together, these findings support key and distinct roles
for eicosanoids in the wound healing process and in its dysregulation/“stalling”. Yet,
therapeutic treatments to modulate these pathways in the clinical setting with the goal of
improving healing outcomes remain limited.
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Eicosanoid synthesis begins with the initial rate-limiting step, formation of AA via
the activity of a phospholipase A2 (PLA2). (J. D. Clark, Schievella, Nalefski, & Lin, 1995;
Leslie, 1997; Pettus et al., 2003; Stephenson, Hoeferlin, & Chalfant, 2017) One of the
major PLA2s involved in this initial step is cPLA2α. Previously, our laboratory
demonstrated that the translocation of cPLA2α to intracellular membranes, as well as AA
release and production of downstream eicosanoids, were dependent upon C1P
interacting with the C2 domain of this enzyme at residue, R59, and possibly R57 and K58.(L.
Alexis Hoeferlin, Wijesinghe, & Chalfant, 2013; Lamour et al., 2009; Stahelin,
Subramanian, Vora, Cho, & Chalfant, 2007a; Ward et al., 2013) Later studies suggested
that both R61 and H62 were also key residues for the C1P interaction and induction of
cPLA2α translocation to membranes.(Stahelin, Subramanian, Vora, Cho, & Chalfant,
2007b) More recently, our laboratory reported that C1P derived from ceramide kinase
(CERK) negatively regulates the migration of murine embryonic fibroblasts. Furthermore,
C1P levels were elevated in the inflammatory phase, but decreased during the
proliferation/remodeling stage in human wound healing using a novel PTFE-insertion
model.(Wijesinghe et al., 2014)
Based on the preceding findings, we hypothesized that the C1P/cPLA2α interaction
regulates wound repair and regeneration. In this study, we tested this premise using a
novel genetic mouse model, and found that this lipid: protein interaction negatively
regulates the later phases of wound healing. To our knowledge, this is the first report of
a defined lipid:protein interaction regulating a biological phenotype in an in vivo
mammalian model. Furthermore, our data suggest a new mechanistic paradigm for
cPLA2α in shifting cell function depending on the association of the enzyme with specific
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lipid mediators. Overall, the data not only reinforce the integral role that eicosanoids play
in the wound healing process by demonstrating a novel role for 5-HETE, but also
demonstrate the importance of protein:lipid interactions, such as the C1P/cPLA2α
interaction.

2.2 RESULTS

Ablation of the C1P/cPLA2α interaction does not affect the closure rate of acute
wounds.
In order to study the role of the C1P/cPLA2α interaction in vivo, a novel genetic
mouse was designed and created with an ablated C1P/cPLA2α interaction (cPLA2α KI
mouse) (Fig.2.1A). This mouse model was designed using a construct with an inserted
cassette containing puromycin resistance, a premature stop codon flanked by loxP sites,
and three mutated amino acids (R57A, K58A, R59A) in the endogenous cPLA2α locus (2.1A,
red stars exon 4). The design enabled generation of a cPLA2α knockout mouse (e.g.,
cPLA2α-KO) that can be converted to the cPLA2α-KI genotype by Cre-mediated
recombination. cPLA2α mRNA levels and genotyping were confirmed via RT-qPCR and
end-point PCR, respectively (Fig.2.1B and C). Of note, the cPLA2α-KO mouse was further
confirmed by demonstrating the reported breeding phenotype for this genetic ablation
model (i.e., dramatic reduction of litters due to spontaneous abortion) (data not shown).
Using our novel genetic models, the cPLA2α wild-type (cPLA2α-WT), cPLA2α-KI, and
cPLA2α-KO mice were examined for acute wound healing using a punch-biopsy model
as reported by Wang and co-workers.(Wang, Ge, Tredget, & Wu, 2013a) Specifically,
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mice were injured using 6 mm biopsy punches on the shaved dorsum, and wounds were
stinted open as described.(Wang, Ge, Tredget, & Wu, 2013b) The wound closure rate
was observed over the course of 14 days. No significant differences were observed in the
closure rate between the cPLA2α-WT, cPLA2α-KI, and cPLA2α-KO mice (Fig. 2.2). These
data show that both cPLA2α and the C1P/cPLA2α interaction do not play a role in the
closure rate of acute wounds in mice.

Altered wound healing and maturation occurs in cPLA2α KI mice.
The lack of a significant effect on the rate of in vivo wound closure was not
unexpected as the wound closure rate for acute wounds in mice is more dependent on
contraction-based mechanisms in contrast to humans.(GRILLO, WATTS, & GROSS,
1958; Kennedy & Cliff, 1979; McGrath & Simon, 1983) We next examined the wounds for
other healing processes that are similar in mice and humans, such as chemotactic
responses, fibroblast migration, and wound maturation/remodeling.(Galiano, Michaels,
Dobryansky, Levine, & Gurtner, 2004; Wong, Sorkin, Glotzbach, Longaker, & Gurtner,
2011b) Furthermore, since eicosanoids play a pivotal role in the chemotactic response of
cells both in vivo and in vitro,(Sivamani, 2014a; Wijesinghe et al., 2014) histological
evaluations of healed wounds were performed on the cPLA2α-WT, cPLA2α-KI, and
cPLA2α-KO mice. Masson’s trichrome stain of healed wounds (10 days) demonstrated a
dramatic increase in cell infiltration into the healed wound of cPLA2α-KI mice in stark
contrast to both cPLA2α WT and KO mice (Fig. 2.3A).
By day 10, the wound is normally expected to be undergoing both the proliferation
and remodeling phases of wound healing, which involves infiltration and proliferation of
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dermal fibroblasts.(R. A. F. Clark, 1988; Midwood, Williams, & Schwarzbauer, 2004) In
order to determine the cell type infiltrating into the healed wounds of the cPLA2α-KI
mouse, tissue sections were analyzed for a standard immunohistochemical fibroblast
marker, Heat shock protein 47. The tissue sections show that the healed wounds of the
cPLA2α-KI mice contained increased levels of dermal fibroblasts (Fig. 2.3B and E). These
data indicate that the C1P/cPLA2α interaction acts as a negative regulator of fibroblast
migration into the wound environment during the healing process of acute wounds.
To determine whether the enhanced numbers of dermal fibroblasts observed in
the wounds of the cPLA2α-KI mice affected wound repair and maturation negatively or
positively, picrosirius red staining was used to examine collagen deposition.(Schmidt et
al., 2016) A dramatic increase in the ratio of type I to type III collagen in the healed wounds
of cPLA2α-KI mice was observed (Fig. 2.3F). Interestingly, it has been reported that an
increase in type I collagen indicates more advanced progression through the wound
healing process.(Gonzalez et al., 2016; Lorenz & Longaker, 2008) Since type I collagen
deposition correlates with wound maturation, our data demonstrate that the loss of
C1P/cPLA2α interaction positively impacts acute wound healing process.

Ablation of the C1P/cPLA2α interaction in mice is associated with enhanced wound
remodeling and tensile strength.
To determine whether the loss of the C1P/cPLA2α interaction affected the orderly
deposition and cross-linking of collagen rods, electron microscopy was utilized to examine
collagen rod diameters in wound tissue, which has been associated with an increase in
wound tensile strength. A profound difference in the profile of the collagen rods was

18

observed in cPLA2α KI mice compared to cPLA2α-WT and cPLA2α-KO mice (Fig. 2.4A
and B). Specifically, the rod diameter of collagen was dramatically reduced in wounds
from the cPLA2α-KI mice to a range of 10 to 19 nm in contrast to a diameter range of 30
to 49 nm in both cPLA2α-KO and cPLA2α-WT wounds. Since wound strength has been
shown to be associated with both type I collagen deposition as well as smaller collagen
rod diameter in healed wounds, (Khorasani et al., 2011; Pickett, Burgess, Livermore,
Tzikas, & Vossoughi, 1996; Xue & Jackson, 2015) we next examined wound tensile
strength. Importantly, healed wounds of cPLA2α-KI mice exhibited significantly increased
tensile strength as compared to wounds from WT and cPLA2α-KO mice (Fig. 2.4C.).
Taken together, these data indicate that the genetic ablation of the C1P/cPLA2α
interaction enhances wound maturation, remodeling, and repair for acute wounds in mice.

Ablation of the C1P/cPLA2α interaction enhances the migration of primary dermal
fibroblasts.
A large body of research has demonstrated that eicosanoids play a pivotal role in
the orderly migration and meandering of fibroblasts.(Sivamani, 2014b; Wijesinghe et al.,
2014) Because cPLA2α-KI mice showed an enhanced wound maturation phenotype that
was linked to greater fibroblast infiltration and collagen Type I deposition, we next
determined whether this phenotype could be recapitulated in vitro in primary dermal
fibroblast (pDFs). More specifically, we determined whether this cell type was directly
involved in mediating the observed in vivo phenotypes. As shown in Figure 5A-C, no
phenotypic differences in cell appearance and actin fiber distribution were observed for
pDFs from the three genotypes. However, significantly increased migration velocity was
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observed for pDFs from the cPLA2α-KI mouse compared to pDFs from cPLA2α-WT and
cPLA2α-KO mice (Fig. 2.5D-F). Cell meandering was also assessed, but no significant
difference was seen between the genotypes (data not shown). Lastly, collagen deposition
in pDF cells from cPLA2α-KI mice was significantly increased compared to pDFs from
cPLA2α-KO and cPLA2α-WT mice (Fig. 2.5G). The data indicate that C1P/cPLA2α
interaction is a negative regulator of pDF migration speed and collagen deposition but
does not play a significant role in the migration polarity of pDFs.

Ablation of the C1P/cPLA2α interaction alters the lipid profile in primary dermal
fibroblasts.
Because of the known involvement of eicosanoids in regulating fibroblast
migration,11-13 a broad lipidomics screen was performed utilizing UPLC ESI-MS/MS.
Significant decreases in several AA-derived eicosanoids (e.g., PGE2) were observed in
pDFs with the ablated C1P/cPLA2α interaction. Similar findings were observed,
irrespective of mechanical trauma, for cPLA2α-KO cells compared to WT pDFs (Fig. 2.6A,
B, Table 1). Interestingly, however, significant increases in the levels of several HETES
(e.g. 5-HETE and 15-HETE) were observed in cPLA2α-KI pDFs compared to both WT
and cPLA2α-KO pDFs (Fig. 2.6B and C, Table 2.1). These pDF data correlated with lipid
profiles from in vivo wounds, as 5-HETE was increased and PGE2 decreased in cPLA2αKI mice after 10 days (Fig. 2.6D and E, Table 2.2). The data support the novel hypothesis
that the C1P/cPLA2α interaction is functioning as both a positive and negative regulator
of specific eicosanoid biosynthetic pathways.
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To confirm that the altered eicosanoid profile is due to the mutant cPLA2α (mutantcPLA2α [R57A, K58A, R59A]) and not due to off-target activation of a separate PLA2
system, pDFs were treated with a selective cPLA2α inhibitor, pyrrophenone. The
enhanced HETE levels (e.g., 5-HETE) observed in cPLA2α-KI pDFs were blocked by
pyrrophenone without significantly affecting HETE levels in the WT and KO pDFs (Table
2.3).
Unexpectedly, mutant cPLA2α protein expression in the cPLA2α-KI pDFs was
found to be significantly reduced as compared to WT pDFs, whereas mRNA expression
was reduced only 15% (Fig. 2.1B and 2.7A). To demonstrate that the altered eicosanoid
profile was due to the ablation of the C1P/cPLA2α interaction and not reduced protein
expression, both WT and mut-cPLA2α (R57A, K58A, R59A) were re-expressed in KO pDFs
to the same expression level (Fig. 2.7B). Mut-cPLA2α expression in KO pDFs induced the
same eicosanoid profile as the cPLA2α KI pDFs, with even further enhancement of 5HETE production (Fig. 2.7C and D). Notably, expression of the WT cPLA2α in KO pDFs
“rescued” the eicosanoid profile to that of WT pDFs (Fig. 2.7C and D). Mut-cPLA2α
expression also yielded the migration phenotype seen in cPLA2α-KI pDFs (Fig. 2.7E).
These data confirm that the C1P/cPLA2α interaction is not only a positive regulator of a
large number of inflammatory eicosanoids, but also acts as a negative regulator for the
production of 5-lipoxygenase-derived lipid mediators such as 5-HETE. Our data strongly
suggest that ablation of the C1P/cPLA2α interaction leads to the induction of a “gain of
function” phenotype for the enzyme that drives 5-HETE production in pDFs.

5-HETE drives the cPLA2α KI migration phenotype.
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To determine whether the production of specific HETE species was responsible
for the enhanced migration of the cPLA2α KI pDFs, we relied on exogenous addition of
specific eicosanoids and of small molecule inhibitors of pertinent biosynthetic enzymes.
The addition of 5-HETE to WT pDFs, but not 12-, 15-, or 20-HETE recapitulated the
increased migration velocity phenotype of cPLA2α-KI pDFs (Fig. 2.8A and data not
shown). Of note, 5-HETE was the only HETE species to recapitulate the cPLA2α-KI
phenotype in WT pDFs using levels moderately above the concentrations produced by
the cPLA2α-KI pDFs (Fig. 2.8A). We surmised that the production of higher PGE 2 levels
in WT pDFs as compared to cPLA2α-KO and cPLA2α-KI pDFs necessitates higher levels
of 5-HETE to increase the migration velocity, because PGE2 is a known inhibitor of
fibroblast migration (Fig. 2.8A). To test the validity of this idea, pDFs from cPLA2α-KO
mice, which produce almost no PGE2, were treated with various concentrations of 5HETE. In contrast to WT pDFs, extremely low levels of 5-HETE were able to enhance the
migration velocity of these pDFs to the same extent as observed for cPLA2α-KI pDFs (Fig.
2.8B). These data show that the loss of the C1P/cPLA2α interaction produces the optimal
eicosanoid pattern for enhanced pDF migration by providing reduced levels of migrationsuppressing eicosanoids (i.e., PGE2) while increasing the levels of the pro-migratory lipid
mediator, 5-HETE.
In control studies, pyrrophenone was again used to treat pDFs to show that the
effects on migration velocity are due to the mutant cPLA2α (mutant-cPLA2α R57A, K58A,
R59A]) and not off-target activation of a separate PLA2 system. The enhanced migration
velocity of cPLA2α-KI pDFs was blocked by addition of pyrrophenone, with no significant
effects observed for the WT and KO pDFs (Fig. 2.9A). These data support the finding that
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the enhanced migration velocity observed in the cPLA2α-KI pDFs is due to a “gain of
function” or “shift in function” exerted by the mutant enzyme. To further reinforce the role
of 5-HETE in regulating pDF migration, MK886, an inhibitor of Five Lipoxygenase
activating protein (FLAP), was used to block 5-LO production of 5-HETE. MK886
treatment of both WT and cPLA2α-KO pDFs had no significant effect on pDF migration
velocity as compared to untreated samples (Fig. 2.9B). In contrast, MK886 significantly
decreased the migration velocity of cPLA2α-KI pDFs to that of WT pDFs (Fig. 2.9B), in
contrast to sham-treated cPLA2α-KI DFs (not shown). Lastly, cPLA2α-KI pDFs were
treated with combinations of pyrrophenone, MK886, and 5-HETE. Exogenous addition of
5-HETE “rescued” the cPLA2α-KI phenotype in both the pyrrophenone- and MK886treated cPLA2α-KI pDFs (Fig. 2.9C). Together, these data support the conclusion that
ablation of the C1P/cPLA2α interaction induces production of 5-HETE, at the expense of
PGE2 production, with the net effect of enhancing pDF migration.

cPLA2α KI dermal fibroblasts display altered colocalization of the 5-lipoxygenase
activating protein (FLAP) and cPLA2α
Previous work has demonstrated that localization and expression of synthetic
enzymes play a key role in the levels of both HETE and leukotriene production.(Rådmark,
Werz, Steinhilber, & Samuelsson, 2015) Thus, we explored the mechanism used by
mutant-cPLA2α enzyme to drive 5-HETE production at the expense of other inflammatory
eicosanoids. Immunocytochemistry coupled to confocal microscopy revealed both FLAP
and cPLA2α to be cytosolically localized in cPLA2α-KI pDFs, in stark contrast to the
nuclear localization of FLAP and Golgi/peri-nuclear localization of cPLA2α in WT pDFs
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(Fig. 2.10A and B). Moreover, mut-cPLA2α and FLAP were co-localized in cPLA2α-KI
pDFs, again, in stark contrast to their localization in WT pDFs. Also, FLAP protein
expression was significantly decreased in the cPLA2α-KI pDFs as compared to WT pDFs
(Fig. 2.10D and E). These data demonstrate that the increased 5-HETE production by the
cPLA2α KI mutant arises not only from FLAP differential expression, but also from
cytoplasmic co-localization of FLAP with mut-cPLA2α.

DISCUSSION
In order to explore whether the C1P/cPLA2α interaction plays a significant role in
the wound healing process; our lab designed and utilized a novel genetic model where
the C1P interaction site in cPLA2α was ablated. This mouse model demonstrated: (1)
increased dermal fibroblast infiltration into the wound environment; and (2) enhanced
progression through the stages of wound healing as measured by a significant increase
in Type I collagen deposition, reduced collagen rod diameter, and dramatically enhanced
wound strength. These novel phenotypes were linked to an altered eicosanoid profile
observed in pDFs and the wounds themselves. Our mechanistic studies showed that the
loss of inflammatory prostaglandins with a concomitant increase in 5-HETE was key to
driving the observed fibroblast phenotypes. Overall, these data support a role for the
C1P/cPLA2α interaction in the inflammatory stage of wound healing, thus serving as a
negative regulator of the proliferation and remodeling stages of the healing process.
Therefore, blocking C1P production or the interaction of this lipid with cPLA2α could be
beneficial

in

“compressing”

the

inflammatory

phase

and

inducing

the

proliferation/remodeling phases earlier. Indeed, our laboratory reported that C1P levels
24

were increased concomitantly with the inflammatory stage of wound healing in human
subjects, followed by a significant decrease during the proliferation and remodeling
stages.(Contaifer et al., 2017) Thus, exogenous 5-HETE or an inhibitor of the
cPLA2α/C1P interaction may provide significant healing improvement. This may also be
adaptable to chronic wounds such as pressure ulcers, which are “stalled” in the
inflammatory stage with a failure to resolve. Indeed, the continued association of cPLA2α
with membrane C1P may be a key cellular mechanism linked to the “stalling” of the wound
healing process in pressure ulcers. This hypothesis is supported by the knowledge that
cyclic C1P generation by sphingomyelinase D from the venom of the Brown Recluse
spider leads to ulcerated wounds in humans. (DeLozier, Reaves, King, & Rees, 1988;
Hadanny, Fishlev, Bechor, Meir, & Efrati, 2016)
An unexpected finding from this study is the “gain of function” observed for the
mutant cPLA2α. From past research reported by our laboratory, the interaction of
ceramide-1-phosphate with cPLA2α was hypothesized to be required for the function of
the enzyme. Whereas we confirmed our original findings, demonstrating that the loss of
the C1P/cPLA2α interaction suppresses some prostaglandins such as PGE2, it was
completely unexpected to both observe an increase in HETEs as well as novel
phenotypes for the cPLA2α KI mouse in comparison to the cPLA2α KO mouse. As a
specific cPLA2α inhibitor blocks both the increased HETEs and migration of pDF from
cPLA2α KI mice, the differential effects from the cPLA2α KO are likely due to a “gain of
function” of the mutant enzyme versus a developmental adaptation inducing the utilization
of a separate PLA2 class. This was further confirmed by expressing mutant cPLA2α in
cPLA2α KO cells, which induced the same novel lipid profile and migration phenotype.
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These observations support a model in which the mutant-cPLA2α shifts its cellular
location, due to the inability to bind C1P in the basal and induced conditions, and now colocalizes with biosynthetic enzymes associated with 5-HETE production (Fig. 2.11A and
B). These data demonstrate a potential mechanism in which loss of the cPLA2α-C1P
interaction induces an altered enzyme localization that, through unknown means, recruits
FLAP and inhibits FLAP nuclear localization to drive 5-HETE production.
In regard to our proposed mechanism, the question remains as to how loss of the
C1P/cPLA2α interaction “shifts” the enzyme to a previously uncharacterized function
inhibited in the presence of C1P in specific cellular membranes. Indeed, the enzyme has
multiple regulatory mechanisms as well as calcium-dependent and -independent
functions. As C1P usually requires the presence of calcium to interact with the enzyme,
loss of the interaction may “shift” cPLA2α to a more calcium-independent role usually akin
to PIP2 regulation of the enzyme. Our previous work with both PIP2 and C1P activation of
cPLA2α suggests this possibility, as the presence of C1P inhibits the calcium-independent
activation of cPLA2α by PIP2 in vitro, and C1P has higher affinity for the enzyme than
PIP2.(Subramanian, Vora, Gentile, Stahelin, & Chalfant, 2007) As PIP2 is a calciumindependent, allosteric activator of cPLA2α, the loss of association with C1P may “shift”
the enzyme to PIP2-enriched membranes, and lead to the utilization of a different
substrate pool linked to Five Lipoxygenase (5-LO) utilization of the released free fatty acid
(Fig. 2.11). Our data demonstrating co-localization of the mut-cPLA2α with FLAP in
contrast to the WT enzyme supports this temporal, “shifting” theory. It is intriguing to
hypothesize that this shift from C1P- to PIP2-mediated regulation of cPLA2α is a key step
in the transition from the inflammatory stage of wound healing to the proliferation stage.
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Future studies are on-going to examine this new hypothesis in depth, which will help
elucidate unknown interactions surrounding the temporal interplay and agonist specificity
of these different regulatory mechanisms of cPLA2α.
One conundrum in this study is the finding that C1P is an inhibitor of pDF migration
via association with cPLA2α. Indeed, a number of laboratories have reported that
exogenous C1P treatment induces the migration of various cell types including
fibroblasts.(C. Kim, Liu, Kucia, & Ratajczak, 2011; Ordoñez, Rivera, Presa, & GomezMuñoz, 2016; Wijesinghe et al., 2014) Our findings in this study as well as a previous
report examining cellular models of ceramide kinase ablation suggest that these
differences are likely due to the cellular context, with C1P derived from ceramide kinase
localized to more internal membranes and acting as a negative regulator of cellular
migration. On the other hand, C1P possibly generated via other anabolic pathways at the
plasma membrane or other cellular localities may enhance migration via association with
factors such as annexins as reported by Kester and co-workers.(Hankins et al., 2013) As
exogenous C1P treatment tends to only significantly increase the C1P content of the
plasma membrane in a number of cell types, a “pool” of C1P at this cellular membrane
may be the “driver” of migration observed by others. At least one additional anabolic
pathway for C1P generation exists in mammalian cells, since CERK ablation only reduces
the cellular context of C1P approximately 50%. As to the identity of this unknown anabolic
pathway, the generation of C1P via an S1P-acylase has been reported.(Binoda,
Portoukalian, Schmitt, Rodriguez-Lafrasse, & Ardail, 2004) Additional studies are needed
to elucidate these anabolic pathways for C1P as well as distinct cellular functions for
individual pathways in various cellular contexts and cellular localities.
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Another intriguing, but as of yet, unexplainable observation is the dramatic
differential localization of FLAP in the cPLA2α KI pDFs as compared to WT. Indeed, FLAP
was localized primarily in the nucleus in WT pDFs, in complete contrast to its cytoplasmic
localization in cPLA2α KI cells. Very little is known about FLAP translocation, as it was
initially considered to be only a nuclear membrane protein, but recent work by Bozza and
colleagues (Bozza, Magalhães, & Weller, 2009) has demonstrated that FLAP can be
found in organelles such as lipid bodies (lipid droplets). This was of note due to the
importance that lipid bodies play in many cellular signaling pathways, such as lipid
metabolism,

membrane

trafficking,

and

regulation

of

inflammation.

Indeed,

phosphoinositides play key roles in the signaling platforms related to lipid bodies such as
cellular trafficking and autophagy (Skotland, Hessvik, Sandvig, & Llorente, 2018; Wallroth
& Haucke, 2018), which supports our hypothetic model of mut-cPLA2α shifting to these
cytoplasmic localities via association with phosphoinositides and co-localizing with FLAP.
This concentration of enzymes as well as the altered localization of FLAP allows for
greater colocalization with the mutant cPLA2α observed in our cPLA2α-KI, which in turn
may explain increased HETE production seen in the cPLA2α-KI.
In conclusion, this study shows that the C1P/cPLA2α interaction plays an important
role in the wound healing process, which was tested through a series of rigorous
experiments. First, we demonstrated that fibroblasts migrated more rapidly into the healed
wounds of cPLA2α-KI mice compared to WT and cPLA2α-KO mice. Second, we
demonstrated that increased cell migration was coupled to increased type I collagen
deposition as well as increased tensile strength of healed wounds in cPLA2α-KI mice.
Third, pDFs from these genotypes showed increased migration velocity among cPLA2α-
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KI cells compared to WT and cPLA2α-KO cells. Fourth, we identified differences in the
eicosanoid profile of all three genotypes, and demonstrated that exogenous addition of
5-HETE recapitulated the migration phenotype previously observed in the cPLA2α-KI
pDFs. Lastly, we used enforced gene expression and specific inhibitors to demonstrate
that the observed phenotype was not due to altered expression or adaptation issues, but
rather due to the genetic ablation of the C1P/cPLA2α interaction. This study shows the
importance of lipids, and more specifically eicosanoids, in the wound healing process and
should act as a stepping stone for further research in the development of drugs, to
increase the healing rate and strength of wounds.

2.3 Methods and Materials
Western Immunoblotting
Western blot analysis was performed as described previously (DeLigio, Lin,
Chalfant, & Park, 2017; Shapiro et al., 2016; Vu et al., 2016) using 20 µg of protein from
each extract. Monoclonal anti-cPLA2α (Santa Cruz Biotech - cPLA2α- (4-4B-3C); 1:200),
rabbit polyclonal anti- cPLA2α (Abcam - cPLA2α - (ab135825); 1:200), and rabbit
polyclonal anti-FLAP (Abcam - FLAP - (ab85227); 1:800), was used to identify the protein
of interest. Anti β-actin antibody (1:5000) (Cell Signaling) was used as a normalizing
factor.
RNA Isolation, Reverse Transcription-PCR, and Quantitative PCR
To evaluate expression of cPLA2α, a RNeasy kit (Qiagen) was used to isolate total
RNA as previously described(Shultz et al., 2012). Next total RNA (1µg) was reverse29

transcribed using Superscript III reverse transcriptase (Invitrogen) according to the
manufacturer’s protocol. Following cDNA synthesis cPLA2α expression was monitored
using quantitative PCR and TaqMan technology (Applied Biosystems) specific to cPLA2α
with GAPDH as a control/normalizing factor. Premixed primer-probe sets, and TaqMan
Universal PCR master mix were purchased from Applied Biosystems, and the cDNA was
amplified using CFX Connect real-time PCR detection system (Bio-Rad). Gene
expression levels were calculated by the ΔΔCt method, normalized to GAPDH
expression, and presented as fold of mean values ± SD.
PCR-based identification of WT, cPLA2α-KI, and cPLA2α-KO
Genotyping of WT, cPLA2α-KI, and cPLA2α-KO mice was performed by first
collecting genomic DNA using an Accustart II genotyping kit followed by polymerase chain
reaction (PCR) using the following primers: PLA2 58780-58757, 5’-TGCCAGATGTGAACTTACTTCCAG-3’; PLA2 58534-58556, 5’-TGAGGGTCGTGCTGTAGAGTTAG-3’;
and SV40 2590-2567 5’-CTGCATTCTAGTTGTGGTTTGTCC-3’. 50ng of genomic DNA
was used for each reaction along with the following primer concentrations, cPLA2α-KI: 0.2
μmol/L PLA2 58780-58757 and 0.2 μmol/L PLA2 58534-58556, cPLA2α KO: 0.2 μmol/L
PLA2 58780-58757, 0.1 μmol/L PLA2 58534-58556, and .1 μmol/L SV40 2590-2567
additionally the following reaction cycles were repeated 33 times, 94°C for 1 min, 59°C
for 1 min, and 72°C for 2 min. Reaction products expected are as follows WT: 237bp,
cPLA2α-KI: 412bp, and cPLA2α KO:361bp and were examined using a 2% agarose gel.
Isolation of mouse dermal fibroblasts
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Primary mouse dermal fibroblasts (pDFs)were isolated from 10-week-old WT,
cPLA2α-KI, and cPLA2α-KO C57/Blk6 males as previously described.(Seluanov, Vaidya,
& Gorbunova, 2010) Once harvested cells were cultured using high glucose DMEM
(Gibco) supplemented with 20% FBS (Gibco) and 2% penicillin/streptomycin (Bio
Whittaker) at standard incubation conditions. Cells were not used after passage 5.
Soluble collagen assay
Primary DFs obtained from WT, cPLA2α-KI, and cPLA2α-KO mice were plated at
a density of 5.0 x 103/well of a 96 well plate in high glucose DMEM supplemented with
20% FBS (GIBCO) and 2% penicillin/streptomycin (Bio Whittaker) and allowed to adhere
at grow standard incubation conditions for 24 h. Following the 24-hour incubation period,
collagen deposition was measured using a soluble collagen assay from Cell BioLabs.
Briefly, media was removed, and cells were allowed to dry overnight in a 37°C oven.
Following the drying period, cells were washed with distilled water and then stained using
Sirius Red Reagent. After a 60 min incubation the Sirius Red Reagent was removed, and
cells were washed with 5% acetic acid four times. Extraction solution was then applied to
each well and allowed to incubate at room temperature for 30 min. Following the
incubation period, 100 µl of extraction reagent was removed from each well and placed
in a new well. Collagen levels were then assessed by absorbance at 540-560 nm in each
well.
Excisional biopsy punch
6 mm excisional wounds were generated by first anesthetizing 10-week-old WT,
cPLA2α-KI, and cPLA2α-KO C57/Blk6 males and shaving their dorsum, after the dorsum
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was shaved, alcohol and iodine was used to prep the surgical site, at which point a 6 mm
biopsy punch (Miltex) was used to create two 6 mm hole punches on the dorsum of the
mice. Silicone stints were then place around the wound and a combination of 6 sutures
and glue were used to hold said stints in place. Wounds were dressed using Tegaderm
(3M Medical) and imaged over the course of 14 days. Wound images were analyzed
using the Fiji image J bundle.
Histology
6 mm excisional wounds were generated by first anesthetizing 10-week-old WT,
cPLA2α-KI, and cPLA2α-KO C57/Blk6 males and shaving their dorsum, after the dorsum
was shaved, alcohol and iodine was used to prep the surgical site, at which point a 6 mm
biopsy punch (Miltex) was used to create two 6mm hole punches on the dorsum of the
mice. Silicone stints were then place around the wound and a combination of 6 sutures
and glue were used to hold said stints in place. Wounds were dressed using Tegaderm
(3M Medical) and allowed to heal for 10 days. After 10 days, wounds were excised and
prepared for histological evaluation using the following procedure. Excised wounds were
fixed by placing them in 4% paraformaldehyde for 24 hours, following fixation the wound
was placed in a cassette that allowed for the dehydration of the tissue, followed by
clearing of the tissue using xylene (Fisher brand), and finally imbedding the tissue in
paraffin wax. Sections (5 µm) of the paraffin block were placed on clear glass slides for
further treatment and staining. Staining and probing for Masson’s trichrome, picrosirius
red, and Hsp47 (rabbit polyclonal anti-Hsp47 (Abcam – Hsp47 - (ab109117); 1:4000))
were performed by Histo-Scientific Research Laboratories Inc.
Immunocytochemistry
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Primary dermal fibroblasts from WT, cPLA2α-KI, and cPLA2α-KO were seeded into
24 well tissue culture plates that contained round cover slips (Electron Microscopy
Science) at a density of 3.5 x 104/well and fixed for 20 min in 4% paraformaldehyde,
following 4% paraformaldehyde fixation cells were washed 3x in PBS and then treated
with 100% ice cold methanol for 5 min. Following the fixation and methanol treatment
cells were immunolabeled as previously described(Benusa, George, Sword, DeVries, &
Dupree, 2017; Vu et al., 2013) with the following antibodies: mouse monoclonal anticPLA2α (Santa Cruz Biotech - cPLA2α- (4-4B-3C); 1:50), rabbit polyclonal anti-FLAP
(Abcam - FLAP - (ab85227); 1:100), mouse monoclonal anti-calnexin (Abcam - calnexin
- (ab22595); 1:50), and rabbit polyclonal anti-Hsp47 (Abcam – Hsp47 - (ab109117);
1:4000).

All secondary antibodies were obtained from Invitrogen Life Technologies

(Grand Island, NY; Alexa™ Fluor) and used at a dilution of 1:500.
Wound Tensile strength
20 mm incisional wounds were generated by first anesthetizing 10-week-old WT,
cPLA2α-KI, and cPLA2α-KO C57/Blk6 males and shaving their dorsum. After the dorsum
was shaved, alcohol and iodine were used to prep the surgical site, at which time a ruler
& marker were used to mark a 20 mm line. A scalpel (Bard-Parker) was used to form a
single sagittal incision along the line on the dorsum. Wounds were dressed using butterfly
stitches and self-adhesive medical tape. Mice were monitored, and any mice that
removed their dressing within 72 h were removed from the study. Wounds were allowed
to heal for 10 days, at which point, the wound was excised and trimmed into a bar bell
shape, so that the midsection was 5 mm wide and the length was 20 mm. Once trimmed,
samples were placed on a materials testing equipment, MTS Synergie 100 (MTS
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Corporation, Eden Prairie MN) and stretched to failure at a displacement rate of
10mm/minute,

as

standard

protocol

performed

previously for

wound

tensile

strength.(Mohammed et al., 2015)
Scratch-induced mechanical trauma of fibroblasts
Primary DF’s obtained from WT, cPLA2α-KI, and cPLA2α-KO mice were plated at
a density of 2 x 106 on 10 cm tissue culture plates in high glucose DMEM supplemented
with 20% FBS (GIBCO) and 2% penicillin/streptomycin (Bio Whittaker) and left overnight
to adhere at standard incubation conditions. Following the overnight incubation cells were
rested in 2% FBS (GIBCO) 2% penicillin/streptomycin (Bio Whittaker) high glucose
DMEM (Gibco) for 2 hours. After the 2-hour resting period the media was exchanged
with 0% FBS (GIBCO) 2% penicillin/streptomycin (Bio Whittaker) high glucose DMEM
(Gibco) and mechanical trauma was induced on the monolayer by performing scratched
across the diameter of the plate in an asterisk pattern using 4 20 µl pipette tips on a
multichannel micro pipettor. Media was taken for lipidomic analysis at multiple time points
(0 h and 2 h).
Eicosanoid Preparation and Analysis
Eicosanoid Preparation
Eicosanoids were extracted using a modified extraction process from previously
described. (Blaho, Buczynski, Brown, & Dennis, 2009; Simanshu et al., 2013) Media from
cells (4 mL) was combined with an IS mixture comprised of 10% methanol (400 μl) and
glacial acetic acid (20 μl) before spiking with internal standard (20 μl) containing the
following deuterated eicosanoids (2 pmol/μl, 40 pmol total) (All standards purchased from
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Cayman Chemicals): (d4) 6keto-Prostaglandin F1α, (d4) Prostaglandin F2α, (d4)
Prostaglandin E2, (d4) Prostaglandin D2, (d8) 5-Hydroxyeicosa-tetranoic acid (5-HETE),
(d8) 12-Hydroxyeicosa-tetranoic acid (12-HETE) (d8) 15-Hydroxyeicosa-tetranoic acid
(15-HETE), (d6) 20-Hydroxyeicosa-tetranoic acid (20-HETE), (d11) 8,9 Epoxyeicosatrienoic acid, (d8) 14,15 Epoxyeicosa-trienoic acid, (d8) Arachidonic acid, (d5)
Eicosapentaenoic acid, (d5) Docosahexaenoic acid, (d4) Prostaglandin A2, (d4)
Leukotriene B4, (d4) Leukotriene C4, (d4) Leukotriene D4, (d4) Leukotriene E4, (d5)
5(S),6(R)-Lipoxin A4, (d11) 5-iPF2α-VI, (d4) 8-iso Prostaglandin F2α, (d11) (±)14,15-DHET,
(d11) (±)8,9-DHET, (d11) (±)11,12-DHET, (d4) Prostaglandin E1, (d4) Thromboxane B2, (d6)
dihmo gamma linoleic acid, (d5) Resolvin D2, (d5) Resolvin D1, (d5) Maresin2, and (d5)
Resolvin D3. Samples and vial rinses (5% MeOH; 2 ml) were applied to Strata-X SPE
columns (Phenomenex), previously washed with methanol (2 ml) and then dH 2O (2 ml).
Eicosanoids eluted with isopropanol (2 ml), were dried in vacuuo and reconstituted in
EtOH:dH2O (50:50;100 μl) prior to UPLC ESI-MS/MS analysis.
Analysis of Eicosanoids by UPLC ESI-MS/MS
Eicosanoids were separated using a Shimadzu Nexara X2 LC-30AD coupled to a
SIL-30AC auto injector, coupled to a DGU-20A5R degassing unit in the following way as
previously described by us.(Simanshu et al., 2013) A 14 minute, reversed phase LC
method utilizing an Acentis Express C18 column (150mm x 2.1mm, 2.7µm) was used to
separate the eicosanoids at a 0.5 ml/min flow rate at 40°C as previously described by
us(Simanshu et al., 2013). The column was equilibrated with 100% Solvent A
[acetonitrile:water:formic acid (20:80:0.02, v/v/v)] for 5 min and then 10 µl of sample was
injected. 100% Solvent A was used for the first two minutes of elution. Solvent B
35

[acetonitrile:isopropanol:formic acid (20:80:0.02, v/v/v)] was increased in a linear gradient
to 25% Solvent B at 3 min, to 30% at 6 min., to 55% at 6.1 min, to 70% at 10 min, and to
100% at 10.10 min. 100% Solvent B was held constant until 13.0 min, where it was
decreased to 0% Solvent B and 100% Solvent A from 13.0 min to 13.1 min. From 13.1
min to 14.0 min. Solvent A was held constant at 100%.
Eicosanoids were analyzed via mass spec using an AB Sciex Triple Quad 5500 Mass
Spectrometer as previously described by us (Simanshu et al., 2013). Q1 and Q3 were set
to detect distinctive precursor and product ion pairs. Ions were fragmented in Q2 using
N2 gas for collisionally induced dissociation. Analysis used multiple-reaction monitoring
in negative-ion mode. Eicosanoids were monitored using precursor → product MRM
pairs. The mass spectrometer parameters used were: Curtain Gas: 20; CAD: Medium;
Ion Spray Voltage: -4500V; Temperature: 300°C; Gas 1: 40; Gas 2: 60; Declustering
Potential, Collision Energy, and Cell Exit Potential vary per transition.
Migration analysis of fibroblasts
Cells were seeded into 24 well tissue culture plates at a density of 7.5 x 10 4 and
allowed to grow to confluence. Once a confluent monolayer was achieved cells were
placed in 2% FBS (GIBCO)/2% penicillin/streptomycin (Bio Whittaker) high glucose
DMEM media and allowed to rest for 2-hours. After the 2-hour resting period, the media
was exchanged with 0% FBS (GIBCO) high glucose DMEM media (Gibco), and
mechanical trauma was induced on the monolayer by performing scratched across the
diameter of each well using a 20µl pipette tip. Cells were observed using a live cell
incubation chamber mounted on a Keyence BZ-X710 microscope, which took images
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every 3 min for 24hr. Migration Velocity and meandering index were calculated using the
Keyence VW-9000 motion analysis software.
Exogenous addition of eicosanoids on dermal fibroblasts
Cells were seeded into 24-well tissue culture plates at a density of 7.5 x 10 4 and
allowed to grow to confluence. Once a confluent monolayer was achieved, cells were
placed in 2% FBS (GIBCO) High Glucose DMEM media (GIBCO) containing the addition
of various eicosanoids at the following concentrations (20 ng/mL PGE 2, 0.25ng/mL 5HETE, 0.5ng/mL 5-HETE, 1 ng/mL 5-HETE, and 5 ng/mL 20-HETE) and allowed to rest.
After the 2-hour resting period, the media was exchanged with 0% FBS (GIBCO), high
glucose DMEM media (GIBCO) containing the addition of various eicosanoids at the
following concentrations (20 ng/mL PGE2, 0.25ng/mL 5-HETE, 0.5ng/mL 5-HETE, 1
ng/mL 5-HETE, and 5 ng/mL 20-HETE). Following the media exchange a single scratch
was performed down the diameter of each well using a 20

l pipette tip and cells were

observed using a live cell incubation chamber mounted on a Keyence BZ-X710
microscope, which took images every 3 min for 24 hr. Migration velocity and meandering
index were calculated using the Keyence VW-9000 motion analysis software
Adenoviral treatment of fibroblasts
Migration velocity studies
Cells were seeded into 24-well, tissue culture plates at a density of 7.5 x 104 and
allowed to grow to confluence. The following day, cells were infected with adenovirus
containing either GFP-cPLA2α (WT), GFP-cPLA2α(R57A/K58A/R59A), or an adenoCMV-control virus (100, 100, and 50 multiplicity of infection, respectively) After 72 hours
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cells were placed in 2% FBS (GIBCO) High Glucose DMEM media (GIBCO) for two hours.
Following the resting period media was exchanged with 0% FBS (GIBCO) 2%
penicillin/streptomycin (Bio Whittaker) high glucose DMEM (GIBCO). Following the media
exchange a single scratch was performed down the diameter of each well using a 20 µl
pipette tip and cells were observed using a live cell incubation chamber mounted on a
Keyence BZ-X710 microscope, which took images every 3 min for 24hr. Migration
Velocity and meandering index were calculated using the Keyence VW-9000 motion
analysis software.
Lipid profile studies
pDFs obtained from WT, cPLA2α-KI, and cPLA2α-KO mice were plated at a density
of 2 x 106 on 10 cm tissue culture plates in high glucose DMEM supplemented with 20%
FBS (GIBCO) and 2% penicillin/streptomycin (Bio Whittaker) and left overnight to adhere
at standard incubation conditions. The following day cells were infected with adenovirus
containing either GFP-cPLA2α (WT), GFP-cPLA2α (R57A/K58A/R59A), or an adenoCMV-control virus (100, 100, and 50 multiplicity of infection, respectively) as described
previously described by us.(Lamour & Chalfant, 2008) After 72 hours cells were placed
in 2% FBS (GIBCO), High Glucose DMEM media (GIBCO). After the 2-hour resting period
the media was exchanged with 0 FBS (GIBCO) High Glucose DMEM media (GIBCO) and
mechanical trauma was induced on the monolayer by performing scratches across the
diameter of the plate in an asterisk pattern using 4X20 µl pipette tips on a multichannel
micro pipettor. Media was taken for lipidomic analysis at multiple time points (0 h and 2
h).
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Electron microscopy
6 mm excisional wounds were generated by first anesthetizing 10-week-old WT,
cPLA2α KI, and cPLA2α KO C57BL/6 males and shaving their dorsum, after the dorsum
was shaved, alcohol and iodine was used to prep the surgical site, at which point a 6mm
biopsy punch (Miltex) was used to create two 6mm hole punches on the dorsum of the
mice. Silicone stints were then place around the wound, and a combination of 6 sutures
and glue were used to hold said stints in place. Wounds were dressed using Tegaderm
(3M Medical) and allowed to heal for 10 days. After 10 days, mice were transcardially
perfused with a phosphate buffered solution containing 5% glutaraldehyde and 4%
paraformaldehyde (pH 7.3). Whole carcasses were post-fixed for 2 weeks in the same
solution to ensure optimal tissue preservation. For all studies, 6 mm hole biopsies were
taken of the wounded area processed for standard transmission electron microscopic
analysis as previously described.(Moyon et al., 2016) Briefly, the skin sections were postfixed in 1% osmium tetroxide buffered in 0.1M cacodylate, dehydrated in increasing serial
dilutions of cold ethanol and infiltrated and embedded in PolyBed resin. Each skin section
was oriented for transverse analysis. One micron and ultrathin sections were collected
and stained with sodium borate containing 0.1% toluidine blue. 0.1% methylene blue and
0.1% azure blue and uranyl acetate and lead citrate respectively. For the EM analysis, a
JEOL JEM 1400 transmission electron microscope equipped with a Gatan Ultrascan
digital camera system was employed to collect a minimum of 4 electron micrographs per
animal. These images were used to determine the collagen rod diameter as described by
Khorasani and colleague.(Khorasani et al., 2011)
Small molecule inhibitor studies
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Migration velocity studies
Cells were seeded into 24-well, tissue culture plates at a density of 7.5 x 104 and
allowed to grow to confluence. Once a confluent monolayer was achieved cells were
placed in 2% FBS (GIBCO) High Glucose DMEM media (GIBCO) containing the addition
of either MK886 (7.5 nM) (cayman chem), pyrrophenone (10 nM) (cayman chem), or a
combination of MK886/pyrrophenone and 5-HETE (1 ng/ml) for two hours. Following the
resting period media was exchanged with 0% FBS (GIBCO) 2% penicillin/streptomycin
(Bio Whittaker) high glucose DMEM (GIBCO) containing the addition of either MK886 (7.5
nM) (Cayman Chemical), pyrrophenone (10 nM) (cayman chemical), or a combination of
either MK886/pyrrophenone and 5-HETE (1 ng/ml). Following the media exchange, a
single scratch was performed down the diameter of each well using a 20 µl pipette tip and
cells were observed using a live cell incubation chamber mounted on a Keyence BZ-X710
microscope, which took images every 3 min for 24 h. Migration velocity and meandering
index were calculated using the Keyence VW-9000 motion analysis software.
Lipid profile studies
pDFs obtained from WT, cPLA2α KI, and cPLA2α KO mice were plated at a density
of 2 x 106 on 10 cm tissue culture plates in high glucose DMEM supplemented with 20%
FBS (GIBCO)/2% penicillin/streptomycin (Bio Whittaker) and left overnight to adhere at
standard incubation conditions. Following the overnight incubation, cells were rested in
2% FBS (GIBCO), High Glucose DMEM media (GIBCO) containing the addition of
pyrrophenone (10nm) (cayman chem). After the 2-hour resting period the media was
exchanged with 0% FBS (GIBCO), High Glucose DMEM media (GIBCO) containing the
addition of pyrrophenone (10 nM) (Cayman Chemical) and mechanical trauma was
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induced on the monolayer by performing scratches across the diameter of the plate in an
asterisk pattern using 4X20 µl pipette tips on a multichannel micro pipettor. Media was
taken for lipidomic analysis at multiple time points (0 h and 2 h).
Ethical considerations
The mouse studies were undertaken under the supervision and approval of the
VCU IACUC (Protocol# AM10089) and USF IACUC (Protocol# IS00004094 and
IS00004110) following standards set by the Federal and State government. The animal
assurance number for VCU is #D16-00180 (A3281-01). USF and VCU are fully accredited
by AAALAC International as program #000434 and #000036 respectively, is managed in
accordance with the Guide for the Care and Use of Laboratory Animals, the Animal
Welfare Regulations, the PHS Policy, the FDA Good Laboratory Practices, and the
IACUC Principles and Procedures of Animal Care and Use, has an assurance #D1600589 (A4100-01) on file with OLAW/PHS and maintains registration #58-R-0015 with
USDA/APHIS/AC.
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Figure 2.1 Strategy and design of the novel cPLA2α KI mice.
(A) A schematic representation of the cassette inserted at the beginning of
endogenous exon 4 used to generate both the cPLA2α KI and cPLA2α KO mice used in
this study. The cassette contains a puromycin resistance gene followed by a premature
stop codon, both of which are flanked by two loxP sites. Additionally, the cassette contains
a triple mutation at the C1P binding site, R57A, K58A, R59A at the beginning of exon number
four. Following the addition of CRE recombinase, the puromycin resistance gene and
premature stop codon are excised allowing for the production of cPLA2α with the mutated
C1P binding site. (B) WT, cPLA2α KI, and cPLA2α KO primary dermal fibroblasts (2.0 x
106 cells/100-mm plate) were allowed to grow for 24 hours and then harvested for RNA
collection. RNA from WT, cPLA2α KI, and cPLA2α KO primary dermal fibroblasts was
converted to cDNA and used for quantitative PCR analysis using primers specific to the
cPLA2α gene (applied biosciences TaqMan). (C) Genotypic analysis of WT, cPLA2α KI,
and cPLA2α KO was performed by collecting DNA from mouse tails, analyzing via PCR,
and examining the resulting products using gel electrophoresis. When using the cassette
specific primer sets, three bands are possible the WT at 237 bp, the cPLA2α KI at 412 bp,
and cPLA2α KO at 361 bp. Samples were compared using ANOVA followed by Tukey's
post-hoc test. Data shown are means + SD, n = 3 samples per group, ****P< 0.0001.
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Figure 2.2 Ablation of the C1P/cPLA2α interaction does not affect the in vivo wound
closure rate.
Closure rate of acute wounds in C57/BLK6 WT, cPLA2α KI, and cPLA2α KO mice
were observed using the stinted excisional wound model previously described by Wang
and colleagues.(Wang et al., 2013b) (A) shows no significant difference in wound closure
rate between C57BL/66 WT, cPLA2α KI, and cPLA2α KO mice. (B) Percent opened wound
of C57/BLK6 WT, cPLA2α KI, and cPLA2α KO over course of 14 days. Samples were
compared using ANOVA followed by Tukey's post-hoc test. Data shown are means + SD,
n = 5 mice per group.

45

46

Figure 2.3 Histological evaluation of healed wounds from WT, cPLA2α KI, and
cPLA2α KO mice demonstrated a distinct phenotypical difference.
Using the stinted excisional wound model as previously described (Wong, Sorkin,
Glotzbach, Longaker, & Gurtner, 2011a) the histology of healed wounds from WT, cPLA2α
KI, and cPLA2α KO mice were observed. (A) Representative Masson’s trichrome stained
sections from WT, cPLA2α KI, and cPLA2α KO mice 10 days post excisional wounding
demonstrated significantly increased levels of collagen (dark blue color) and infiltrating
cells (cell nuclei (purple)) in cPLA2α KI mice as compared to both WT and cPLA2α KO
mice. (B) Wound sections were probed for the fibroblast marker Hsp47, which
demonstrated that cPLA2α KI mice had significantly increased levels of fibroblasts in
healed acute wounds. (C) Further examination of the wound sections using brightfield
microscopy and Picrosirius red demonstrated differential levels of collagen deposition in
cPLA2α KI mice (collagen Type I = dark pink; collagen Type III = light pink). (D)
Additionally, the use of polarized light microscopy revealed increased levels of Type I
collagen (dark red) versus Type III collagen (yellow) in cPLA2α KI mice when compared
to both the WT and cPLA2α KO mice. (E) Graphical representation of the cell counts
performed on Hsp47 probed sections. (F) Graphical representation of the ratio of type I
vs. type III collagen in Picrosirius red stained sections examined under polarized light.
Samples were compared using ANOVA followed by Tukey's post-hoc test. Data shown
are means + SD, n = 4 mice per group, *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001.
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Figure 2.4 Healed wounds from WT, cPLA2α KI, and cPLA2α KO mice demonstrate
differences in collagen rod diameter and wound tensile strength.
(A) Transmission electron microscopy (TEM) images of stinted excisional wounds
allowed to heal for 10 days were collected from WT, cPLA2α KI, and cPLA2α KO mice.
These images demonstrated a difference in the rod diameter profile of cPLA2α KI as
compared to both WT and cPLA2α KO mice. (B) Graphical representation of data from
TEM images. (C) Further exploring the phenotype, a 2 cm incisional wound was made on
the shaved dorsum of WT, cPLA2α KI, and cPLA2α KO mice and allowed to heal for 10
days. Healed wounds were then collected, and wound tensile strength was measured
on materials testing equipment. Samples were compared using ANOVA followed by
Tukey's post-hoc test. Data shown are means + SD, n = 2-3 mice per group for TEM, n =
4-7 mice per group for wound tensile strength, *P< 0.05, **P< 0.01.
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Figure 2.5 The loss of the C1P/cPLA2α interaction causes an increase in migration
velocity and collagen deposition in primary dermal fibroblasts.
(A-C) Actin distribution was examined in primary dermal fibroblasts collected from
WT, cPLA2α KI, and cPLA2α KO mice, and no significant differences were observed
between the three genotypes. (D, E, and F) Migration velocity in all three genotypes was
observed as described in the methods using a Keyence bz-x710 microscope with live cell
incubation chamber attachment. When examining migration in all three genotypes, a
significant difference in migration velocity was observed in the cPLA2α KI pDFs when
compared to WT and cPLA2α KO sample. (G) In addition, we examined the collagen
deposition rate of WT, cPLA2α KI, and cPLA2α KO pDFs and discovered that at 24hr post
plating, cPLA2α KI pDFs deposited collagen with an increased rate as compared to both
WT and cPLA2α KO pDFs. Samples were compared using ANOVA followed by Tukey's
post-hoc test. Data shown are means + SD, n = 6-12 samples per group, *P< 0.05, **P<
0.01, ***P< 0.001, ****P< 0.0001.
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Figure 2.6 Genetic ablation of the C1P/cPLA2α interaction affects eicosanoid
synthesis in primary dermal fibroblasts and healed excisional wounds.
In order to examine the lipid profile of primary dermal fibroblasts from WT, cPLA2α
KI, and cPLA2α KO mice, cells where cultured as described in the experimental
procedures. Media containing secreted eicosanoids were quantified at 2 hours post-injury
via HPLC ESI-MS/MS as described in Experimental Procedures. (A) Significant decrease
in PGE2 is seen in both cPLA2α KI and cPLA2α KO pDFs as compared to the WT control
cells. (B) Complete lipid profile of WT, cPLA2α KI, and cPLA2α KO pDFs shown as fold
change in comparison to WT controls. (C) cPLA2α KI pDFs display a significant increase
of 5-HETE as compared to both WT and cPLA2α KO pDFs. In order to further our
investigation of the of the C1P/cPLA2α interaction on eicosanoid formation, an in vivo
approach was used in where 6 mm biopsy punches were used to remove skin from stinted
excisional wounds that had been allowed to heal for 10 days. The skin was than
homogenized via an Omni Tissue Homogenizer on ice and processed for lipid extraction
as previously described in the experimental procedures. (D and E) Similar to the in vitro
study increases in 5-HETE were observed in samples collected from cPLA2α KI mice as
compared to both WT and cPLA2α KO. Samples were compared using ANOVA followed
by Tukey's post-hoc test. Data shown are means + SD, n = 6-8 samples per group for in
vitro studies, n = 3 samples per group for in vivo studies, *P< 0.05, **P< 0.01, ***P< 0.001,
****P< 0.0001.
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Figure 2.7 Viral recapitulation “rescues” the cPLA2α KI phenotype in cPLA2α KO
pDFs.

Evaluation of cPLA2α expression via western immunoblotting demonstrated

a significant difference in the levels of cPLA2α in cPLA2α KI pDFs. (B) Primary dermal
fibroblasts from cPLA2α KO mice were cultured and treated with either GFP-cPLA2α (WT
Virus), GFP- cPLA2α (R57A/K58A/R59A: mut-cPLA2α and Mutant virus), or CMV-GFP
(CMV Control Virus)-expressing adenovirus as described previously (Lamour et al., 2009)
and in the Experimental Procedures. Using the previously described adenoviral
expression system(Lamour et al., 2009), equal levels of either WT or mut-cPLA2α were
expressed in cPLA2α KO pDFs as demonstrated by western immunoblot analysis. (C,D)
Media containing secreted eicosanoids from cPLA2α KO pDFs treated with GFP-cPLA2α
(WT), GFP-cPLA2α (R57A/K58A/R59A), or CMV-GFP control virus were quantified at 2
hours post-injury via HPLC ESI-MS/MS as previously described and as described in
Experimental Procedures.(Wijesinghe et al., 2014) The addition of GFP-cPLA2α (WT) and
GFP-cPLA2α (R57A/K58A/R59A) was able to recapitulate the previously observed lipid
profiles in both cPLA2α WT and cPLA2α KI pDF’s. (D) Further, the increase in 5-HETE
previously observed was also recapitulated in cPLA2α KO pDFs treated with GFP-cPLA2α
(R57A/K58A/R59A) virus as compared to both the GFP-cPLA2α (WT)-and CMV control
virus-treated cPLA2α KO pDFs. (E) Lastly, the migration velocity phenotype observed in
cPLA2α KI pDFs was recapitulated by the addition of the GFP-cPLA2α (R57A/K58A/R59A)
virus in contrast to both GFP-cPLA2α (WT) and CMV-GFP control virus. Samples were
compared using ANOVA followed by Tukey's post-hoc test. Data shown are means + SD,
n = 3-9 samples per group, *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001.
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Figure 2.8 Exogenous addition of specific eicosanoids alters migration velocity in
dermal fibroblasts.
Using the previously described migration velocity assay, pDFs from cPLA2α WT
and cPLA2α KI mice were cultured in order to determine the effect of specific lipid
mediators on migration velocity (A) Live cell imaging demonstrated that the exogenous
addition of specific eicosanoids (i.e.,. PGE2 (20.00 ng/mL) and 5-HETE (1.00 ng/mL))
significantly altered the migration velocity of primary dermal fibroblasts. (B) 5-HETE was
added to cPLA2α KO pDFs in a dose dependent manner (0.00 ng/ml, 0.25 ng/mL, 0.50
ng/mL, and 1.00 ng/mL). Based on these data, 5-HETE does increase migration velocity
at a lower dose in cPLA2α KO pDFs than WT. Samples were compared using ANOVA
followed by Tukey's post-hoc test. Data shown are means + SD, n = 3-10 samples per
group, *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001.
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Figure 2.9 Small molecule inhibitors of cPLA2α and FLAP alter the migration
velocity of cPLA2α KI dermal fibroblasts.
Using the previously described migration velocity assays, pDFs from cPLA2α WT,
cPLA2α KI, and cPLA2α KO mice were cultured in order to determine the effect of various
small molecule inhibitors on migration velocity. (A) The effects of pyrrophenone (10 nM)
on the migration velocity of pDFs from cPLA2α WT, cPLA2α KI, and cPLA2α KO mice were
examined. These data indicate that the cPLA2α inhibitor, pyrrophenone, had no effect on
migration velocity in both the WT and cPLA2α KO pDFs, but had a significant effect on
the cPLA2α KI pDFs as compared to control (cPLA2α WT pDFs). (B) pDFs were treated
using the FLAP inhibitor, MK886 (7.5 nM), and the migration velocity was observed. In
this test, MK886 had no effect on migration velocity in both the cPLA2α WT and cPLA2α
KO pDFs, but had a significant effect on the cPLA2α KI pDFs as compared to control
(cPLA2α WT pDFs). (C) Lastly, the migration velocity was observed in cPLA2α KI pDFs
that were treated with a combination of either MK886 or pyrrophenone and 5-HETE (1
ng/ml). Live cell imaging demonstrated that the addition of both MK886 and pyrrophenone
significantly inhibited the decreased the migration velocity phenotype of cPLA2α KI DFs,
while no significant difference was observed between the WT and cPLA2α KO DFs after
treatment. Furthermore, the exogenous addition of 5-HETE was able to “rescue” the
cPLA2α KI phenotype in both MK886 and pyrrophenone treated cells as no significant
difference was observed in these pDFs when compared to control (cPLA2α KI DFs).
Samples were compared using ANOVA followed by Tukey's post-hoc test. Data shown
are means + SD, n = 4-10 samples per group, *P< 0.05, **P< 0.01, ***P< 0.001, ****P<
0.0001.
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Figure 2.10 Primary dermal fibroblasts from cPLA2α KI mice demonstrate
differential localization of cPLA2α and FLAP.
Primary dermal fibroblasts from WT, cPLA2α KI, and cPLA2α KO mice were
cultured as described in the Experimental Procedures. pDFs were fixed, probed using
anti-FLAP and anti-cPLA2α antibodies, and examined using confocal microscopy. (A and
B) A shift in FLAP localization was observed in cPLA2α KI pDFs. FLAP had a more
cytosolic localization in cPLA2α KI pDFs as compared to the nuclear localization observed
in WT pDFs (yellow arrows). (A and C) Confocal microscopy also revealed a significant
difference in the localization of cPLA2α in cPLA2α KI pDFs. cPLA2α in these pDFs
demonstrated a cytosolic localization when compared to the Golgi/perinuclear localization
observed for cPLA2α in WT pDFs (white arrows). (D and E) Next FLAP expression was
examined using western immunoblot analysis, which revealed a 35-45% decrease in
FLAP expression in cPLA2α KI cells as compared to WT cells. Colocalization was
determined using Pearson’s correlation index, samples were compared using an unpaired
students t-test with Welch’s correction. Data shown are means + SD, n = 4-6 samples per
group for confocal microscopy, n = 4 samples per group for western blot analysis, *P<
0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001.
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Figure 2.11 A schematic depiction of the current mechanistic hypothesis of cPLA2α
regulation in the presence and absence of ceramide-1-phosphate.
(A) The current model of cPLA2α involves: (1) A stimulus increases intracellular
calcium levels, as well as phosphorylation of cPLA2α (2) Translocation of cPLA2α, as
well as association with C1P at intracellular membranes, such as the endoplasmic
reticulum and Golgi (3) Upon membrane binding, cPLA2α preferentially cleaves
arachidonic acid containing phospholipids at the sn-2 location generating free fatty acids
(4) These free fatty acids, such as arachidonic acid are acted on by cellular enzymes,
such as COX1/2, to produce various eicosanoids (eg. PGE2). (B) Based on the data
presented we hypothesize the following model (1) A stimulus increases intracellular
calcium levels, as well as phosphorylation of cPLA2α. Decreased translocation of cPLA2α
to intracellular membranes and a preferred association with PIP2 (3) The differential
binding of cPLA2α to PIP2 versus C1P, as well as the difference in localization, drive
arachidonic acid utilization towards the 5-HETE pathway (4) Differential localization
makes AA produced by mutant cPLA2α highly accessible to intracellular enzymes such
as 5-LO and FLAP, which process arachidonic acid producing 5-HPETE (5) 5-HPETE is
released and process by intracellular peroxidases generating 5-HETE.
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Table 2.1 In vitro lipid profile from mechanically injured primary dermal fibroblasts
from WT, cPLA2α KI, and cPLA2α mice.
Lipid levels of primary dermal fibroblasts from WT, cPLA2α KI, and cPLA2α KO
mice where analyzed as described in the Experimental Procedures. Media containing
secreted eicosanoids were quantified at 2 hours postinjury via HPLC ESI-MS/MS as
described in Experimental Procedures. Samples were compared using ANOVA followed
by Tukey's post-hoc test. Data shown are means + SD, n = 6-8 samples per group
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Table 2.2 In vivo lipid profile in acute excisional wounds from WT, cPLA2α KI, and
cPLA2α KO mice.
Lipid levels were analyzed in acute excisional wounds generated by using 6 mm
biopsy punches to remove skin from stinted excisional wounds that had been allowed to
heal for 10 days. The wounds were homogenized via an Omni Tissue Homogenizer on
ice, processed for lipid extraction, and analyzed by ESI-UPLC-MS/MS as previously
described in the Experimental Procedures. Samples were compared using ANOVA
followed by Tukey’s test. Data shown are means + SD, n = 3 samples per group
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Table 2.3 The altered lipid profile in primary dermal fibroblasts from the cPLA2α KI
mouse is cPLA2α-specific.
Lipid levels of Primary dermal fibroblasts from WT, cPLA2α KI, and cPLA2α KO
mice were analyzed after treatment with pyrrophenone (10 nM), cells where cultured as
described in the Experimental Procedures. Media containing secreted eicosanoids were
quantified at 2 hours post-injury via HPLC ESI-MS/MS as described in Experimental
Procedures. Samples were compared using ANOVA followed by Tukey’s test. Data
shown are means + SD, n = 3 samples per group.
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Chapter 3
Background
The C1P/cPLA2α in Chronic Wounds

2.1 Introduction
Chronic wounds are classified as wounds that are unable to progress through the
stages of healing in an orderly and timely fashion, most often never progressing through
the inflammatory phase. They are classified on a four point scale based on severity (Fig.
3.1), with 1 being the least severe and having no open wound present to 4 in which the
wound has extensive damage revealing bone and muscle at the wound site. (Rosenblum
& Papamichael, 2016) Generally, chronic wounds arise from diabetic foot ulcers, venous
leg ulcers, and pressure ulcers, but are certainly not limited to these injuries. (Frykberg &
Banks, 2015)

To this end, chronic wounds are a growing concern in the medical

community due to the extraordinary costs associated with treatment and care, estimated
in excess of $20B (Järbrink et al., 2017; Nussbaum et al., 2018). While significant work
has been done to further understand the pathologies that cause chronic wounds, more
work is needed to advance the understanding of the molecular and cellular mechanisms
involved in dysregulated wound closure, which often leads to chronic wounds. (Lazarus
et al., 1994)
Unfortunately an issue that continually arises when attempting to study chronic
wounds is finding an appropriate model that recapitulates clinical features often seen in
human wound healing. (Nunan, Harding, & Martin, 2014) With that understanding,
Petreaca and colleagues generated a mouse model deficient in the TNFSF14/LIGHT
gene (LIGHT-/-), which when injured generates wounds with similar pathologies to chronic
70

ulcer injuries seen in human patients.(Petreaca et al., 2012) Using this new model, Dhall
and colleagues examined the role that various signaling lipids play in impaired healing.
This work uncovered increases in various proinflammatory eicosanoids, which may act to
hinder the healing process. In addition, they demonstrated that LIGHT-/- mice had
increases in key eicosanoids involved in the coagulation cascade, which upregulated
coagulation, reducing the bleeding time and increasing the inflammatory phase.(Dhall et
al., 2015a)
The work by Dhall and colleagues ties into work previously discussed in this
dissertation. The LIGHT-/- mouse demonstrated increased proinflammatory eicosanoids
leading to increased inflammation and a prolonged inflammatory phase. In contrast, our
cPLA2α KI mouse displays decreased levels of these same proinflammatory eicosanoids,
and increased levels of specific eicosanoids that enhance cellular infiltration into the
wound. This led us to hypothesize that pressure ulcers in our cPLA2α KI mouse would
heal at an increased rate compared to WT mice.
Using our previously described cPLA2α KI mouse model we investigated the role
of C1P/cPLA2α interactions in wound healing by examining chronic wounds. Excitingly,
unlike the acute wound model, which did not reveal differences between the WT and
cPLA2α KI, pilot studies using a modified version of a previously described pressure ulcer
model (Stadler, Zhang, Oskoui, Whittaker, & Lanzafame, 2004) showed a significant
increase in the rate of healing in cPLA2α KI mice as compared to WT mice. Additionally,
neutrophil infiltration was increased in pressure ulcers from cPLA2α KI mice with
significant numbers of neutrophils present as early as hour 2 as compared to hour 4 in
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WT mice. These preliminary data demonstrate a potential role for the C1P/cPLA2α
interaction in chronic wounds, as well as a potential therapeutic target in the future.

2.2 Methods and Materials
Generation of pressure ulcers
Pressure ulcers were generated in WT and cPLA2α KI C56/Blk6 females at 12
weeks of age by first shaving their dorsum and cleaning with 70% ethanol. Once cleaned
and dry skin on the dorsum was lifted to create a flap and placed between two magnets
(need magnet info), magnets were allowed to stay in place for 16 hours (on cycle), at
which point they were removed, and the skin flap was separated and allowed to lay flat
on the mouse dorsum. The wounded area was allowed to rest for 16 hours (off cycle).
This on/off cycle was performed two additional times for a total of 3 on/off cycles.
Following the on/off cycles images are taken every 24 hours for 14 days.

Histology
Pressure ulcers were generated in WT and cPLA2α KI C56/Blk6 females at 12
weeks of age by first shaving their dorsum and cleaning with 70% ethanol. Once cleaned
and dry skin on the dorsum was lifted up to create a flap and placed between two
magnets, magnets were allowed to stay in place for 16 hours (on cycle), at which point
they were removed, and the skin flap was separated and allowed to lay flat on the mouse
dorsum. Pressure ulcers were excised at various time points (0, 2, 4, 8) and prepared for
histological evaluation using the following procedure. Excised wounds were fixed by
placing them in 4% paraformaldehyde for 24 hours. Following fixation, the wound was
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placed in a cassette that allowed tissue dehydration, followed by clearing of the tissue
using xylene (Fisher brand), and finally imbedding the tissue in paraffin wax. 5 m
Sections of the paraffin block were placed on clear glass slides for further treatment and
staining. Sections were probed using rabbit polyclonal anti-myeloperoxidase (Abcam myeloperoxidase - (ab45977); 1:100) following primary probing sections were treated and
visualized using a HRP/DAB detection kit (Abcam – HRP/DAB (ABC)-(ab64261) per the
manufactures protocol.

Neutrophil isolation
Neutrophils were isolated from the bone marrow of C57/BLK6 WT, cPLA2α KI, and
cPLA2α KO mice via a percoll gradient isolation. Briefly, mice were sacrificed via CO 2
asphyxiation and soaked in 100% ethanol for 30 seconds. Following the ethanol cleaning
step, femurs were removed from tissue and placed in HBSS prep media. Femurs were
cleaned of any excess tissue and the end caps of each femur were removed, exposing
the bone marrow. Using 1 ml of HBSS, femurs were flushed, and bone marrow was run
through a 25g syringe to disperse clumps. The HBSS bone marrow suspension was
centrifuged at 400g in room temp conditions for 5 min. The cell pellet was then
resuspended in 6 ml of 0.2% NaCl for 45 seconds, following the lysis step, osmolarity was
restored by adding 14 ml 1.2% NaCl. The new suspension was filtered using a cell strainer
(70 micron) and re-pelleted at 400g in room temp conditions for 5 min and resuspended
in 1 ml HBSS-prep. Next 5 ml of 62% Percoll (HBSS-prep) solution was added to a 15 ml
tube and the bone marrow solution was slowly layered on percoll using a glass pipette.
The new percoll bone marrow solution was centrifuged at 1000g for 30 min with the brake
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turned off. Following centrifugation, neutrophils were removed from the solution by
isolating the cloudy pellet at the top of the 62.5% percoll gradient and washed twice in
HBSS-prep. Neutrophils were re-suspended and counted for use in appropriate assay.

Transwell migration assay
Transwell migration assays were performed using the QCM Chemotaxis Cell Migration
Assay (EMD Millipore). Briefly, Human umbilical vein endothelial cells (HUVEC) were
plated at a density of 2.5 x105 cells/250µl/well and allowed to adhere and rest for 48 hrs
in the upper well. Following the resting period HUVECs were treated with 20ng/ml of
TNFα for 18 hrs. After the 18 hr treatment period the upper well was gently placed into a
lower well containing 250 ml of media containing 1µg/ml LPS and neutrophils were added
to the upper well at a density of 5.0 x 105/250µl/well. Media from the lower wells were
collected at set time points and analyzed for migration of neutrophils from the upper to
lower well.

2.3 Results

Pressure ulcers generated in cPLA2α KI mice healing at an increased rate as
compared to WT mice.
Using a previously described pressure ulcer model (Stadler et al., 2004), pressure ulcers
were generated in both cPLA2α KI and WT mice. Interestingly unlike the acute wound
model previously discussed, differences in wound closure rate were able to be observed,
in which starting at day 6 the cPLA2α KI mouse demonstrated a significant increase in
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closure rate as compared to WT mice, which continued up until day 9 when on average
both animals had demonstrated completely healed wounds. (Fig. 3.2A and B) These data
lend to the hypothesis that the C1P/cPLA2α interaction plays a significant role in
regulating wound closure in chronic wounds.

Genetic ablation of the C1P/cPLA2α interaction increases neutrophil infiltration
during the healing process.
With the understanding that neutrophils are one of the major cell types regulating the
inflammatory phase and more importantly for this study perpetuating chronic wound
formation, we examined neutrophil infiltration rate after an ischemia reperfusion injury in
dermal tissue. Wounds were generated using a modified version of the pressure ulcer
model, in which only one ischemia/reperfusion cycle was performed. Wounds were then
collected at set time points (0,2,4,8) and probed for neutrophil infiltration using the
neutrophil marker Myeloperoxidase (MPO).(Kinkade et al., 1983) Unexpectedly, cPLA2α
KI tissue samples demonstrated increased neutrophil infiltration as early as 2 hours post
injury when compared to WT samples. (Fig. 3.3A). Using these data as a starting point
,we employed a well-established in vitro trans-well migration assay (Benakanakere et al.,
2016) to examine the migration capabilities of neutrophils. As expected, neutrophils
collected from cPLA2α KI mice migrated more rapidly than WT neutrophils (Fig. 3.3C) To
this point the data demonstrate that in both an in vivo and in vitro model, neutrophils
collected from cPLA2α KI mice infiltrate/migrate at a greater rate than WT neutrophils.
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These data demonstrate that the rate of neutrophil infiltration may be playing a significant
role in the regulation of chronic wounds.
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Figure 3.1 Classification of the four stages of pressure ulcers.
Pressure ulcers are injuries that can occur to skin and the underlying tissue that can range
from mild redness of the skin to full tissue loss in the affected area. Due to the variance
of the injury, healthcare professionals use a four-stage system to describe the severity of
injury to the affect area. Stage 1 is the least severe and classified by having no open
wounds, mild pain, and reddened skin that does not blanch after touch. Stage 2 ulcers
are characterized by a painful open wound, which may extend into deeper layers of tissue.
Most often these wounds appear as blisters, scrapes, and occasionally open craters.
Stage 3 ulcers are classified by significant tissue loss the extends through all the dermal
areas and begins to expose adipose tissue in the injured area. Lastly, stage 4 ulcers are
full thickness wounds that contain severe tissue damage through all layers of tissue,
generally with exposed bone, tendon, and muscle.
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Figure 3.2 Genetic ablation of the C1P/cPLA2α interaction regulates wound
closure in pressure ulcers.
Closure rate of pressure ulcers in C57BL/6 WT and cPLA2α KI mice were observed using
the previously described pressure ulcer model (Stadler et al., 2004). (A) Pressure ulcers
of cPLA2α KI mice close at a significantly increased rate as compared to WT controls (B)
Percent opened wound of C57/BLK6 WT and cPLA2α KI over course of 10 days. Samples
were compared using an unpaired students t-test with Welch’s correction. Data shown
are means + SD, n = 2-14 samples per group, n = 2-12 *P< 0.05, **P< 0.01, ***P< 0.001,
****P< 0.0001.
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Figure 3.3 cPLA2α KI Neutrophils infiltrate wounded tissue at a greater rate than
WT Neutrophils.
Using the previously described ischemia reperfusion model neutrophil infiltration into
wounded tissue was observed at various time points (0,2,4,8) (A) Interestingly,
neutrophils from cPLA2α KI mice appeared to infiltrate into wounded tissue at an
increased rate beginning at hour 2, as compared to hour 4 for WT mice. (B) Transwell
migration data demonstrated cPLA2 KI neutrophils migrated at a significantly increased
rate as compared to both WT and cPLA2α KO neutrophils. Samples were compared using
ANOVA followed by Tukey's post-hoc test. Data shown are means + SD, n = 2 samples
per group, *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001.
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3.4 Discussion
Though chronic wounds can occur in normally healthy individuals a significant
population of individuals suffering with chronic wounds have primary illnesses that
contributed to the formation and continuation of chronic wounds, such as diabetes and
malnutrition. These primary conditions setup an environment allowing the wound
environment to continually re-set and never progress past the inflammatory phase
(Munro, 2017), which makes inflammatory response regulation an important topic of
research in the wound healing field.
Using this knowledge and branching off from previous work in the Chalfant lab we
explored the role of the C1P/cPLA2α interaction in a chronic wound model. We did this by
utilizing our novel cPLA2 KI mouse model to perform preliminary experiments. These
experiments demonstrated that: (1) Pressure ulcer injuries in cPLA 2α KI mice had an
increased wound closure rate; and (2) cPLA2α KI neutrophil infiltration and migration
occur at a greater rate both in vivo and in vitro, as compared to WT neutrophils. We
believe these novel phenotypes to be associated with the genetic ablation of the
C1P/cPLA2α interaction. Interestingly, the generation of C1P from sphingomyelinase D
(SMase D) (Lee & Lynch, 2005) has been shown to be a potent regulator of chronic
wound development, which affirms the hypothesis that continued association of cPLA2α
with membrane C1P may be a key cellular mechanism linked to the “stalling” of the wound
healing process in pressure ulcers.
In conclusion these preliminary experiments demonstrate that the C1P/cPLA 2α
interaction plays a pivotal role in chronic wounds and that by genetically ablating their
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interaction we are able to increase the closure rate of pressure ulcers in a murine model,
additionally, we demonstrated that neutrophils from cPLA2α KI mice infiltrated the wound
site as early as 2 hours post wounding, while WT neutrophils took as long as 4 hours to
infiltrate, and lastly we showed that the increase in infiltration rate associated with cPLA2α
KI neutrophils can be tied to an increase in migration capabilities by using Transwell
migration assays, which showed significantly more migrated neutrophils in cPLA2α KI
samples. To that end, further mechanistic studies will be required to show and confirm
what cell types and signaling molecules are playing a significant role in the observed
phenotype.
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CHAPTER FOUR
DISCUSSION
4.1 Significance
One of the more important points of this study is the demonstration of a specific role for
a defined lipid:protein interaction in vivo. To our knowledge, this is the first time that a
validated lipid:protein interaction has been genetically ablated to discern specific
mechanistic roles at the in vivo level. Whereas many lipid:protein interactions have been
biophysically and cellularly defined (e.g., DAG/PKC interaction, PIP3/AKT), these studies
were not extended to in vivo phenotypes. In the present study, we have bolstered a
decade of enzymology, biophysical assays, and cellular analyses to show that the
C1P/cPLA2α interaction is a major regulator of cPLA2α function, both positively to drive
prostaglandin formation in vivo and negatively to regulate the formation of HETEs, via a
previously unknown “shifting” mechanism. The findings open the door to examination of
the temporal shift in cPLA2α function in cells in response to various inflammatory agonists
in many physiologic contexts. For example, neutrophils and macrophages, depending on
the timing and agonist, may shift their lipid profile to switch from inflammation to
recruitment of more pro-resolution cell types. Furthermore, there is precedent to a shift
between pro-inflammatory and pro-resolution phenotypes in many physiologies (e.g.,
sepsis) and cell types (e.g., macrophages) regulated by cPLA 2α-derived lipids (e.g.,
lipoxins, resolvins). (Schwab & Serhan, 2006; Serhan, 2010; Serhan, Chiang, & Van
Dyke, 2008)
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4.2 Future directions
While great strides have been made in the understanding of the C1P/cPLA2,
interaction further work is still required to fully elucidate all the roles cPLA 2α is able to
play. Future experiments confirming the hypothesis that by genetically ablating the
C1P/cPLA2α interaction we are causing a shift in the function of cPLA2α to a more
calcium-independent role generally associated with PIP2 regulation of the enzyme would
be of particular interest. Additionally, further work examining how genetically ablating the
C1P/cPLA2α is regulating wound closure in pressure ulcers would be exciting. A future
experiment that can potentially answer the question of whether the inflammatory phase
of wound healing is being compressed would involve looking at neutrophil infiltration
during extended time points over the course of the healing process. This can be done
multiple ways, with the ideal way involving crossing a previously described eGFP
lysozyme mouse (Faust, Varas, Kelly, Heck, & Graf, 2000) with the cPLA2α KI and KO
mice describe in the previous studies. Pressure ulcers can then be generated on the
dorsum of mice and using a fluorescent imaging system neutrophil infiltration can be
monitored in real time, which should reveal the time frame for both infiltration and exodus
of neutrophils during the healing process in vivo. An additional experiment would be to
look at inflammatory signaling molecules at various time points, specifically examining
eicosanoid and cytokine levels during the early and late stages of wound closure. This
can be accomplished by first generating pressure ulcers in WT, cPLA 2α KI, and cPLA2α
KO mice, followed by excision of the wound site at various time points, (0,3,5,7,10 days),
at which point the wound can be split in two, one half for eicosanoid analysis and the
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other half for cytokine analysis. Ideally this will give a deeper understanding of the
signaling that is regulating the increased closure rate seen in cPLA2α KI mice.

4.3 Concluding Remarks
To this point we have shown that genetic ablation of the C1P/cPLA2α interaction
causes distinct changes in the infiltration of fibroblasts into the wound environment of
acute wounds, we have also demonstrated that this increased level of infiltration is
associated with wound maturation in the form of greater levels of type I collagen,
decreases in the collagen rod diameter, and increases in the level of stress excisional
wounds are able to tolerate. Next, we showed that specific lipid mediators, such as PGE2
and 5-HETE are capable of regulating fibroblast migration and that the chemical inhibition
of said mediators is able to abolish the migration phenotype. Additionally, we
demonstrated that genetic ablation of the C1P/cPLA2α dramatically alters the localization
of FLAP possibly explaining the increases in 5-HETE production. Lastly, preliminary data
in this study shows that loss of the C1P/cPLA2α interaction increases the rate of wound
closure in a murine pressure ulcer model, as well as increases neutrophil infiltration and
migration both in vivo and in vitro. When examined as a whole, these data clearly indicate
a significant role for the C1P/cPLA2α interaction in wound healing as well as provide a
great understanding of the healing process and the singling mediators that are involved.
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